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ABSTRACT
The mammalian gastrointestinal (GI) tract harbors a complex microbial ecosystem
with hundreds of bacterial species at total levels as high as 101012 cells/g tissue. These
bacteria play an important role in the health of the host as well as in causing disease, but
studies on the roles of the GI microflora are hindered by the lack of a suitable model system.
This thesis characterizes and uses a defined flora mouse model to study interactions between
exogenous bacteria and the GI microflora.
The first part of the thesis characterizes a defined flora mouse model consisting of
immunodeficient C.B-17 SCID mice colonized with the eight bacterial strains of the altered
Schaedler flora (ASF). Specific and sensitive molecular methods were developed to
accurately estimate the levels of different ASF strains. Distribution of specific ASF strains
along the GI tract was dependent on the oxygen tolerance of the strains. Fecal levels of
different strains, which are typically used as a model for colonic bacteria, were different from
colonic levels, although all colonic strains were present in feces. ASF strains were persistent
in the mouse GI tract even in the face of long-term exposure to other bacteria.
The second part of the thesis evaluates the presence of different ASF strains in inbred
and outbred mouse models from different vendors to establish the potential for widespread
use of these strains as representatives of the mouse GI microflora. Seven of the eight strains
were persistent in both inbred and outbred mice from all vendors studied. This indicates the
potential for the ASF strains to be used as a model system even in mouse models that do not
harbor a defined flora.
The third part of the thesis explores ecological interactions following infection by an
intestinal pathogen, Citrobacter rodentium, in defined flora C.B-17 SCID mice. Bulk levels
of the pathogen and the ASF strains in different regions of the large intestine and their spatial
localization across the luminal-mucosal cross-section were assessed. C. rodentium exhibited
accelerated dynamics, and infection was followed by increases in levels of specific ASF
strains and in total bacterial levels in infected mice as compared to control mice. Different
ASF strains were observed to have specific spatial niches that did not vary between infected
and control mice. These results suggest that the role of the microflora in preventing
colonization of pathogens is a complex process that potentially involves more than one
bacterial species.
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INTRODUCTION
The discovery that the human gastrointestinal (GI) tract harbors a large number of
microorganisms came over a century ago and led to two schools of thought. Pasteur,
Metchnikoff and others postulated a positive role and viewed the bacteria favorably, while
Nenchi and others believed that the bacteria were a source of constant irritation and ideally,
humans should be devoid of any bacteria (Schaedler, 1983). Our growing understanding of
the microflora and its interactions with the mammalian host over the last century
demonstrates that both these points of view have validity. Research over the last 50 years has
shown that the GI tract microbial ecosystem is highly diverse and potentially plays a key role
in host's nutrition, intestinal development, prevention of disease, as well as a detrimental role
in causing disease, through a variety of mechanisms, many of which we are only beginning
to understand.
The GI tract ecosystem is diverse in terms of physiochemical properties and potential
substrates for microbial metabolism. There is a gradient in oxygen levels in the GI tract, from
a high level of oxygen in the proximal colon to anaerobic conditions in the colon (He, 1999).
There is also variation in motility, water content and levels of epithelial shedding.
Additionally, there is a distinction in conditions between the mucosal layer and the lumen of
the GI tract. The complex mammalian diet ensures a high level of substrate diversity that
could be exploited by the microflora (Savage, 1977).
All these factors make the GI tract a site for potentially high microbial diversity and
numbers. This is indeed seen to be true, with the total levels of bacteria in the GI tract as high
as 10 10-"/g tissue in the colon. The bacterial load in the GI tract is thought to exceed the total
eukaryotic cell number in the human body by an order of magnitude (Savage, 1977)! There is
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no accurate estimate of the diversity of bacterial species in the GI tract yet. Studies of the
mammalian gut microflora using both culture-based and molecular biological methods have
estimated the diversity to be in the range of several hundred species, most of which are
obligate anaerobes (Moore, 1974, Savage, 1977, Foster, 1984, Suau, 1999). Commonly
isolated species include lactobacilli, clostridia, bacteroides, staphylococci, bifidobacteria and
various coliforms (Dubos, 1965, Savage, 1977, Suau, 1999). Suau et al. also observed that
60-80% of fecal bacteria seen under a microscope cannot be cultivated. This stresses the need
for the development of culture-independent methods and model systems with limited
diversity for studying the gastrointestinal microflora.
The role of complex microflora in the nutrition and metabolism of the host is one of
the important effects of the microflora. The diet of mammals consists of a mixture of simple
and complex carbohydrates, whereas mammalian capabilities of absorption are limited to
simple monosaccharides like glucose and galactose. Microbes digest the dietary
polysaccharides, which would otherwise be excreted unused, into monosaccharides and
ultimately into utilizable short-chain fatty acids such as acetate, propionate and butyrate.
Thus, the microbiota in the GI tract play a significant role in assisting mammals in their
caloric intake (Falk, 1998, Savage, 1986, Hooper, 2002).
A role in the development of the host has also been proposed for the GI microflora.
The intestinal morphology of germfree animals, with very regular ileal villi that have reduced
crypt depth, is distinct from that of animals with a normal microflora (Gordon, 1971).
Colonization by a single commensal organism, Bacteroides thetaiotaomicron, in germfree
mice leads to a wide array of transcriptional changes in the mouse small intestinal cells
including different levels of expression of the genes for several important intestinal functions
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such as nutrient absorption, xenobiotic metabolism and postnatal intestinal maturation
(Hooper, 2001).
The GI microflora is believed to have a significant role in preventing disease
through a phenomenon termed colonization resistance. Several studies have observed that a
reduction in the complexity of the microflora leads to a higher susceptibility of the host to
infections and a lower infectious dose (Wells, 1982, Kennedy, 1985, Vollaard, 1994,
Hudault, 2001, Waidmann, 2003). A hypothesis put forward to explain this phenomenon is
that exogenous pathogens have to compete with the intestinal microflora for attachment to
the gastrointestinal mucosa (Kennedy, 1987, Vollaard, 1994). However, the complexity of
the microflora makes detailed ecological studies of such interactions between the GI
microflora and pathogens difficult. Due to this limitation, such competition has only been
shown to occur in cell culture models where colonization of human epithelial cell surfaces
with lactobacilli or bifidobacteria prevents pathogens from attaching (Bernet, 1993, Resta-
Lenert, 2003). A study to assess colonization resistance to E. coli in germfree mice
monoassociated with Bacteroides vulgatus observed that although B. vulgatus reduced the
severity of disease, no competition for attachment was observed (Waidmann, 2003).
While several of the effects of the microflora are beneficial to the host, GI
bacteria are also believed to be involved in causing disease in susceptible hosts through
autoimmune responses and opportunistic pathogenesis. A proposed harmful effect of the
intestinal microflora is in the pathogenesis of inflammatory bowel diseases (IBD). Studies
have indicated that IBD could be caused by an abnormal immune response to the intestinal
microbiota (Sellon, 1998, Madden, 2002, Bouma, 2003). This reasoning is reinforced by the
fact that germfree mice do not suffer from IBD, while colonization of germfree mice by a
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complex microbiota leads to IBD in susceptible models (Sartor, 1997). Intestinal bacteria
have also been implicated in opportunistic pathogenesis that occurs when the intestinal
ecosystem is disturbed by factors such as antibiotic therapy or immunosuppressant use,
leading to the overgrowth of organisms such as Clostridium difficile that cause colitis (Falk,
1998).
Studies on the GI microflora and its interaction with pathogens and the host are
hindered by the complexity of the microflora. A simple model system that is representative
of the species diversity of the complex flora and is functional would be of immense use in
studying the ecology of microbial interactions in the GI tract, and the effects of these
interactions. One such model system is the set of eight bacterial species called the altered
Schaedler flora (ASF) (Orcutt, 1987, Dewhirst, 1999). The eight bacterial strains include
lactobacilli (ASF360, ASF361), clostridia and related species (ASF356, ASF500, ASF502),
bacteroides (ASF519), eubacteria (ASF492) and a spirillum (ASF457). These bacterial
strains have been used to colonize germfree rodents and protect them from opportunistic
infections for over two decades. Since their phylogeny has been characterized based on 16S
rRNA gene sequence, this provides the opportunity to design sensitive and specific molecular
biological assays to identify and quantify the different ASF species.
The overall goal of this thesis was to put forth defined flora mice colonized with the
altered Schaedler flora as a model system for studying aspects of the microbial ecology of the
mammalian GI tract, and gain insight into pathogen-GI microflora interactions through
experiments in the model. The first part of the thesis (Chapter 2) details the characterization
of the defined flora C.B-17 SCID mouse model. Specific quantitative PCR (QPCR) assays
capable of estimating as few as 10 cells were developed for each ASF bacterial strain and the
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distribution of each strain along the length of the GI tract, from the esophagus to distal colon,
was explored. Since oxygen levels in the GI tract decrease from the stomach to the colon
(He, 1999), one of the objectives was to understand whether ASF strain distribution and
abundance along the GI tract correlates with oxygen tolerance of specific ASF strains. A
second objective was to compare fecal levels of the different ASF strains with levels in the
colon. Fecal levels of bacteria are typically used as a model for colonic levels due to the
difficulty of sampling the colon (Rumney and Rowland, 1992). However, the similarity of
the levels of the microbiota in the colon and feces is not well understood. Another aspect that
was examined was the persistence of the ASF species in mice that were originally defined
flora, but have been maintained under less stringent conditions for several years. The
detection of ASF species in such mice would indicate the ability of the strains to stably
colonize the GI tract even in the face of competition from other bacteria flora.
The second part of the thesis (Chapter 3) assesses the distribution of ASF strains in
inbred and outbred mouse models from several commonly used vendors. The utility of ASF
strains as a representative model of the mouse GI tract flora would be greatly enhanced if
they were commonly found in animal models in widespread use. Indeed, if they were
universally present, they could be used as indicator organisms to compare the microflora in
different groups of animals to ensure consistency between experiments. ASF strains were
used by vendors to colonize germfree breeding stocks of animal models, but the production
stocks of the animals are not maintained under strict gnotobiotic conditions and are subject to
competition from other organisms present in food, water and the environment. The presence
and abundance of different ASF strains in C.B-17 SCID and Swiss Webster mice from three
large vendors was evaluated.
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The final part of the thesis (Chapter 4) involves a detailed analysis of the ecological
interactions between an exogenous pathogen, Citrobacter rodentium, and the ASF strains in
C.B-17 SCID mice over a period of 21 days following infection with C. rodentium. Both
bulk scale effects, in terms of overall levels /g tissue, and spatially resolved effects, in terms
of the localization of the different ASF strains in the luminal-mucosal cross-section, are
assessed through the use of QPCR and fluorescence in situ hybridization respectively. The
motivation behind this experiment was to understand if overall levels and spatial niches of
the normal microbiota potentially change in response to an enteric infection with a microbial
pathogen. Results from this study could shed light on the potential role of competition for
adhesion to the mucosal wall as a mechanism responsible for the colonization properties of
the GI microbiota.
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ABSTRACT
The overall complexity of the microbial community in the gastrointestinal (GI) tract
of mammals has hindered observations of dynamics and interactions of individual bacterial
populations. Yet such information is crucial for understanding the diverse disease-causing
and protective roles gut microbiota play for their hosts. Here, we determine the spatial
distribution, inter-animal variation and persistence of bacteria in the most complex defined
flora (gnotobiotic) model system to date, viz. mice colonized with the eight strains of the
Altered Schaedler flora (ASF). Quantitative PCR protocols based on the 16S rRNA sequence
of each ASF strain were developed and optimized to specifically detect as few as 10 copies
of each target. Total numbers of the ASF strains were determined in the different regions of
the GI tract of three C.B-17 SCID mice. Individual strain abundance was dependent on
oxygen-sensitivity, with aerotolerant Lactobacillus murinus ASF361 present at 105-107
cells/g tissue in the upper GI tract and obligate anaerobic ASF strains being predominant in
the cecal and colonic flora at 108-1010 cells/g tissue. The variation between the three mice
was small for most ASF strains, except for Clostridium sp. ASF502 and Bacteroides sp.
ASF519 in the cecum. A comparison of the relative distribution of the ASF strains in feces
and the colon indicated large differences suggesting that fecal bacterial levels may provide a
poor approximation of colonic levels. All the ASF strains were detected by PCR in the feces
of C57BL/6 Restricted Flora mice, which had been maintained in an isolator without sterile
food, water, or bedding for several generations, providing evidence for the stability of these
strains in the face of potential competition by bacteria introduced into the gut.
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INTRODUCTION
The mammalian body harbors large microbial populations on the skin, in the oral
cavity and in the genital and gastrointestinal (GI) tracts. The number of bacteria is thought to
exceed the number of mammalian cells by as much as a factor of 10 and a majority of
bacteria are present in the GI tract (26). Culture-dependent studies of the bacterial
populations in the gut of mice have indicated about 109 bacteria/g tissue in the stomach and a
gradient of bacterial density along the intestine, with the numbers changing from 107
bacteria/g tissue in the small intestine to 1011 -1012 bacteria/g tissue in the cecum and colon
(5, 6, 26). No culture-independent estimates of bacterial density are available for the GI tract;
however, comparison of direct counts and culturing indicates that between 40-80% of
anaerobic bacteria in fecal matter have not been cultured (18). Although the culturability of
bacteria in the GI tract exceeds that of many other environments studied (2), the lack of
culture-independent cell counts indicates that the gut remains a poorly characterized
ecosystem.
The nature of the GI tract changes along its length, with reduced flow rates and
oxygen levels as ingested matter travels from the stomach to the large intestine. These
factors, combined with the abundance of substrates, make the gut an ecosystem that could
support a complex bacterial community with high spatial heterogeneity (5, 9, 26). Indeed, in
culture-based studies, the bacterial populations mirror this gradient along the length of the
gut. Aerotolerant bacteria such as enterococci and lactobacilli are predominant in the
stomach and small intestine and obligate anaerobic species such as clostridia and bacteroides
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are predominant in the large intestine (6). Overall, anaerobes are thought to exceed
facultative aerobes by a ratio of 1000:1 (5).
Both culture-based and molecular ecological studies have indicated that the gut
microflora are very diverse. Studies of the human fecal flora using culture-based methods
have suggested that over 400 species could be present (20). While culture-based assessment
of species diversity can be misleading due to subjectivity in defining species, recent
molecular studies have indicated a similarly high level of diversity. Analysis of a 16S rRNA
clone library constructed from human fecal DNA found 82 phylotypes, where phylotypes
were defined as sequences with greater than 98% similarity (32). A similar study of the pig
GI tract used amplification products from pooled ileal, cecal and colonic DNA from a pig to
generate a 16S rRNA clone library. 375 phylotypes were detected when phylotypes were
defined as sequences with greater than 97% similarity (19).
The GI microflora are thought to have a major effect on the host but the extent and
mechanisms of influence of the GI microbiota on the host are only beginning to be
understood (11). Several studies have indicated a role for the gastrointestinal microflora in
providing essential nutrients such as Vitamin K (27), differentiation of the host intestine (11),
immune development of the host (7) and protection of the host from pathogenic infections
(10, 15, 30, 33). Comparison of gnotobiotic mice colonized with a single bacterial species
with germfree mice have shown a marked effect on gene expression in the tissues of the
small intestine (12) and a significant increase in the survival rate following infection with a
pathogen (13). On the other hand, the microflora are also postulated to play a role in the
progression of diseases. An example of the potentially harmful nature of the microbiota are
their role in the development of inflammatory bowel disease (IBD) and cancer (3, 25). While
26
the role of Helicobacter hepaticus in causing persistent hepatitis and liver cancer in mice has
been known since the early 1990s, recent studies in immune dysregulated (C.B-17 SCID)
gnotobiotic mice have shown that infection with Helicobacter hepaticus may result in IBD
(3).
Major limiting factors in studying interactions of the GI microbiota with the host are
both the complexity and potential variation of bacterial populations. Thus, defined flora
(gnotobiotic) animal models have become useful tools for the study of the effects of the
microbiota on the host (7, 8) and germfree mice inoculated with a single bacterial species
have been used as the simplest gnotobiotic model system for the study of bacterial effects.
Another simplifying approach involves the use of fecal microflora as a surrogate for the
study of the colonic microflora (23, 26). The representative nature of the fecal flora has not
been established (23) and a recent study comparing the qualitative molecular fingerprints of
the colonic mucosal flora with fecal flora found significant differences (35). Thus, the
development of a widely available defined-flora mouse model that is more complex, and thus
more realistic, than monoassociated models would assist in the study of the consortium
effects of the gut microflora.
Here, we introduce a novel application of mice colonized with the eight-member
altered Schaedler flora as a model system for quantitatively studying the microecology of the
murine gut. The original Schaedler flora, developed in 1965, was used to colonize germfree
mice and consisted of eight aerobic and aerotolerant species isolated from mice. These flora
were selected on the basis of their persistence from generation to generation in germfree mice
and their ability to restore cecal morphology, similar to that of normal mice, in ex-germfree
animals (29). It was later modified to include a spiral bacterium as well as more extremely
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oxygen sensitive (EOS) strains to make it representative of the nature of the gastrointestinal
flora (21). The defined flora substantially reduced the cecal size of germfree mice indicating
their functional similarity to the complex microbiota of normal mice. This defined flora,
known as the altered Schaedler flora (ASF), has become the standard flora to colonize
germfree rodents worldwide (21). Several members of this flora were also detected in a
recent study that assessed the diversity of the mouse GI microbiota using clone libraries (24).
Because gnotobiotic immunodeficient (SCID) mice colonized with the ASF strains have
recently been used as a model system to study development of IBD (3), a characterization of
the ASF strains in this mouse model would greatly enhance its utility. The bacteria in the
ASF have been phylogenetically characterized based on their 16S rRNA gene sequence (4).
The aerotolerant bacterial species, ASF360 and ASF361, are lactobacilli. ASF360 clusters
with L. acidophilus while the 16S gene sequence of ASF361 is identical to L. murinus and L.
animalis. ASF519 is related to Bacteroides distasonis while ASF356, ASF502 and ASF492
fall in the Clostridium cluster XIV, the last being identical to Eubacterium plexicaudatum.
ASF457 is a spiral-shaped bacterium that clusters with the Flexistipes species while ASF500
is not closely related to any of the sequences in the database and clusters with the low G+C
gram positive bacteria (4).
The goals of this study were to (1) develop protocols for the quantification of the ASF
strains based on their 16S rRNA genes, (2) assess the variation of the ASF strains along the
length of the gastrointestinal tract, (3) evaluate the differences between mice and (4) compare
fecal levels to colonic levels.
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MATERIALS AND METHODS
Strain culture. Eight bacterial strains comprising the ASF were obtained from
Taconic (Germantown, NY). Strains ASF360 and ASF361 were grown on MRS agar (Difco
Labs, MI) under microaerobic conditions generated using the Campypak system (Remel,
KS). The rest of the ASF strains were cultured as recommended (22) on Schaedler agar
supplemented with 5% defibrinated sheep's blood (Remel, KS) in an anaerobic glove box
(Coy Laboratories, MI) containing a 10% C0 2-10% H2-80% N2 atmosphere at 34-35*C.
Schaedler agar plates were pre-reduced for 2 days prior to inoculation of the Extremely
Oxygen Sensitive (EOS) strains, which require an anaerobic glove box for successful culture.
However, even under these conditions, EOS strains ASF500 and ASF502 did not grow well.
Whole cell lysates of these two strains (kind gift of Dr. Bruce Paster, Forsyth Institute,
Boston, MA) were used to obtain genomic DNA for testing the specificity of the primers and
for generation of QPCR standards (see below). Liquid cultures were grown at 37*C in MRS
broth (ASF360 and ASF361) or in Schaedler broth supplemented with 5% heat inactivated
fetal calf serum (ASF356 and ASF519).
Mice. Six-week old female C.B-17 SCID mice inoculated with the ASF strains were
obtained from Taconic (Germantown, NY). This age was chosen based on the fact that the GI
microflora reach their climactic level after four weeks (5, 6). The mice were transferred into
an autoclaved SCID cage upon receipt and fed autoclaved food and water. In order to avoid
contamination of the mice with additional species of bacteria, the mice were euthanised after
1 day of arrival at the animal facility, as opposed to the standard 72 h period for recovery
from transportation stress. The stability of the ASF strains in a more complex biota was also
assessed using fecal pellets obtained from 9-month old female C57BL/6 restricted flora (RF)
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mice. The original founders of the RF breeding colony were defined flora before being bred
and maintained in an isolator without sterile food, water, or bedding. Hence, they may have
acquired a more complex flora than the original defined flora. There is evidence for a more
complex microbiota in these mice from terminal Restriction Fragment Length Polymorphism
(t-RFLP) analysis of their fecal bacterial DNA (unpublished results). The RF mice used in
this experiment were maintained in a cube isolator (CRL, MA) with HEPA filtered air and
were fed non-sterile feed and water. All mice were maintained and handled as per IACUC
guidelines.
Sample collection. Three C.B-17 SCID mice were euthanized by CO 2 asphyxiation
and their entire gastrointestinal tract was collected aseptically. The GI tract was divided into
five anatomically defined segments- esophagus, stomach, small intestine, cecum and colon.
The stomach was incised, rinsed free of ingesta, separated into the glandular and non-
glandular portions and 0.5-cm samples were taken from each portion. The cecum was
divided into the basal (including the ileocecal valve) and the apical halves, with the loss of
some of the cecal ingesta. 0.5cm samples were then collected from the ileocecal valve and
the apical cecum. The small intestine was sub-divided into six equal-length segments. Due to
approximation errors and the accuracy of the measurement method, the last segment was
consistently longer than the others. The colon was sub-divided into 3 equal segments. Full
thickness samples, which include the tissue as well as luminal contents, consisting of the first
0.5 cm of each intestinal segment were collected. Prior to sectioning of the colon, formed
fecal pellets were expelled from the colon and collected for analysis from each mouse. All
the samples were weighed immediately and stored at -80'C prior to DNA extraction.
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DNA extraction. (i) Tissue samples. DNA was extracted from tissue samples with
the DNEasy Tissue kit, using a modification of the DNEasy tissue extraction protocol
(Qiagen, CA) to ensure maximal lysis of both Gram-positive and Gram-negative bacteria.
Following overnight digestion of tissue samples with proteinase K (201A, 12mAU) and buffer
ATL (Qiagen, CA), the sample was centrifuged and DNA was isolated from the supernatant.
Briefly, the supernatant was treated with 400tg RNase A for 2 min at room temperature,
incubated with a guanidium isothiocyanate-based buffer AL for 10 min at 70'C and applied
to a spin column. Following washes with buffer AWl and buffer AW2, the DNA was eluted
in elution buffer AE. The pellet from the centrifugation of the lysed tissue was subjected to
an extraction using the DNEasy protocol for Gram-positive bacteria, to ensure recovery of
any possibly recalcitrant Gram-positive bacteria. Briefly, the pellet was resuspended in a
lysozyme buffer (20mM Tris.Cl, pH 8.0, 2mM EDTA, 1.2% Triton X-100), incubated at
85*C for 10 min to inactivate the proteinase K and 3.6 mg of lysoyme (Sigma, MO) was
added to the resuspended pellet. Following a 45-min incubation at 37*C, 400 [g of RNase A
was added to the lysate and incubated at room temperature for 2 min. Proteinase K (25 [L, 15
mAU) and buffer AL were added to the lysate and incubated at 70'C for 30 min. Following
addition of 200 l of ethanol, the lysate was applied to a spin column, washed with buffers
AWl and AW2 and eluted in elution buffer AE as above. DNA from both the extractions
was pooled and stored at -80*C prior to use for quantitative PCR.
(ii) Fecal pellet samples Since bead-beating protocols have been shown to be more
effective in extracting bacterial DNA from fecal samples (34), a bead-beating protocol
adapted from Stahl et al. (31) was used for the fecal pellet samples. Briefly, the fecal pellet
samples were resuspended in Phosphate Buffer Saline (pH 7.4). Tris-saturated phenol (pH
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7.4) (500[l), 0.1mm Zirconium beads (0.5g) and 20% Sodium Dodecyl Sulfate (50t l) were
added to the tube and shaken at 5000 rpm for 2 min on a Bead beater (Biospec, OK). This
step was repeated after a 10 min incubation at 60*C, following which the supernatant was
transferred to a new tube and an equal volume of phenol-chloroform-isoamyl alcohol
(25:24:1) was added. The tube was mixed by inversion and centrifuged for 5 min at 12000xg.
The supernatant was transferred to a new tube and the same procedure was repeated twice.
Following this, an equal volume of chloroform (Sigma, MO) was added to the aqueous
phase, the tube was mixed by inversion and centrifuged at 12000xg for 5 min. DNA from the
supernatant was then precipitated using 0.1 volume of 3M Sodium acetate and a volume of
isopropanol equal to that of the aqueous phase. The DNA was pelleted by centrifugation at
15000xg for 10 min, washed with 70% ethanol, dried under a vacuum using a SpeedVac
(Thermo Corporation, MA) and resuspended in Tris-chloride buffer. Losses in extraction of
different samples were kept constant by using constant volumes at all the steps.
The modified Qiagen Tissue protocol was compared with the bead beating protocol
by extracting DNA from identical mixtures of Lactobacillus murinus ASF361 (Gram
positive) and Citrobacter rodentium (Gram negative) using both protocols and quantifying
the number of bacteria in the extracted DNA. The two protocols yielded comparable results
for both Gram positive and Gram negative bacteria (data not shown).
Primers. (i) Primer design. A secondary structure based alignment of the 16S rRNA
gene sequences of the ASF strains (4) was made against the E. coli 16S rRNA gene using
Seqlab (Genetics Computing Group, WI). Candidate primers were designed based on
sequence stretches in the alignment unique for each ASF strain. These candidate primers
were checked against Genbank using the BLAST algorithm (1) and hits that were perfect
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matches only for the ASF strain in question or other identical 16S sequences in the Genbank
database were selected. If non-ASF sequences had perfect matches for the primers, forward
and reverse primers that did not match the same non-ASF sequence were preferentially
chosen. The other parameters considered in designing the primers, besides specificity, were
primer length (preferably 18-22 bases), dissociation temperature (>58'C) and amplicon size
(optimally <200bp). Primer dissociation temperatures and amplicon sizes in this range are
recommended to enhance QPCR performance. The melting temperatures of the selected
sequences were determined using the PrimerExpress software (Applied Biosystems, CA).
Primers were synthesized and PAGE-purified by IDT DNA Technologies (Coralville, IA).
(ii) Specificity testing. The specificity of the primers was tested by amplifying DNA
from the target organism in a background of fecal pellet DNA from restricted flora mice and
primers that only yielded a band of the expected size were selected for QPCR.
Amplifications were performed using the AmpliTaq kit (Applied Biosystems, CA) on a
Robocycler (Stratagene, CA) with the following conditions: 3 min at 94*C, 35 cycles of 1
min at 94*C, 1 min at 60'C, 2 min at 72'C. After PCR, the amplification products were run
on a 2% agarose gel (Invitrogen, CA) in Tris Borate EDTA buffer and visualized on the
EagleEye Gel documentation system (Stratagene, CA).
QPCR standards. Linearized plasmids containing the 16S rRNA gene of each ASF
strain were used as standards. The 16S rRNA gene from each of the ASF strains was
amplified using bacteria-specific 16S primers 27F and 1492R (17) and cloned into a pCR2.1
plasmid vector using the Topo-TA cloning kit (Invitrogen, CA). The plasmids were
sequenced using the BigDye terminator kit (Applied Biosystems, CA) to ensure that the
primer regions were not altered due to Taq polymerase error. Prior to use for generating
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standard curves, the plasmids were linearized with the restriction enzyme BamHI (NEB, MA)
that cuts the vector exactly once and does not have a recognition site in the 16S rRNA genes
of the ASF strains. The concentrations of the linearized plasmid were determined on a
Synergy HT microplate fluorescence reader (Bio-Tek, VT) using the PicoGreen kit
(Molecular Probes, OR) and dilutions of known concentrations of k DNA as standards.
QPCR optimization. (i) MgC12 optimization. Increasing the concentration of MgCl 2
in the QPCR reaction can make the reaction more efficient, but can also lead to non-specific
amplification. To optimize the MgCl 2 concentration, primers were tested in a range of MgCl 2
concentrations (2-5 mM in increments of 0.5 mM) against all the ASF strains in a
background of fecal pellet DNA from restricted flora mice to ensure an absence of non-
specific amplification. PCR conditions were the same as those used for testing specificity.
Amplification products were analyzed on a 2% agarose gel (Invitrogen, CA) and visualized
using the EagleEye gel documentation system (Stratagene, CA). The highest MgCl2
concentration that did not yield non-specific amplification products (4 mM) for any of the
ASF strains was used as the optimal concentration for all reactions.
(ii) Primer concentration. Higher primer concentrations can increase the efficiency
of the QPCR reaction, but can also lead to primer dimer formation. All combinations of 100
nM, 200 nM and 300 nM forward and reverse primer concentrations were tested with
approximately 106 copies of plasmid template. QPCR reactions were performed in duplicate
for each of the nine possible primer concentration pairs, along with corresponding no-
template controls, using the SYBR Green core reagents kit (Applied Biosystems, CA) and
the QPCR conditions specified below. The primer concentrations yielding the lowest
threshold cycle value for the plasmid standard and highest threshold cycle value for the no-
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template control were chosen as the optimal concentrations for QPCR. Where no significant
change between the different primer concentrations was seen, i.e. intra-assay variation was
similar to inter-assay variation, the lowest concentrations (100 nM, 100 nM) were considered
optimal. None of the primers formed primer dimers at the optimal concentrations.
QPCR reaction conditions. All reactions were performed in triplicate on the DNA
Engine Opticon Continuous Fluorescence Detection System (MJ Research, MA) in a 25[d
reaction volume using the SYBR Green core reagents kit (Applied Biosystems, CA) and the
following reaction conditions: 95'C 10 min, 40 cycles of: 95*C 30 sec, 60'C 45 sec, 72'C 75
sec. The MgCl 2 concentration, optimized as specified above, was kept constant at 4.0 mM for
all the reactions. Melting curves were generated post-QPCR to test for purity by
identification of the characteristic melting peak. This was done by measuring the
fluorescence of the amplification product every 0.1 C while increasing the temperature from
50*C to 95'C. Standard curves for individual ASF strains were generated using a ten-fold
dilution series of the linearized plasmid standard ranging from 1-108 copies. The fluorescence
level for determining the threshold cycle (CT) was set at 0.01 fluorescence units in all
reactions. It was observed that the small intestinal samples and some of the ileocecal samples
had a very high background of eukaryotic DNA, which increased the fluorescence
background in the QPCR reactions. These samples were diluted ten-fold for QPCR.
Assessment of persistence of ASF strains in RF mice. To determine whether the
ASF strains persisted in RF mice, DNA extracted from fecal pellets was amplified with the
strain-specific primers using the conditions specified in Table 1 and the following
amplification conditions: 3 min at 94'C, 35 cycles of 1 min at 94*C, 45 sec at 60*C, 75 sec at
72*C. After PCR, the amplification products were run on a 2% agarose gel (Invitrogen, CA)
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in 0.5 x Tris Borate-EDTA electrophoresis buffer and visualized on the EagleEye Gel
documentation system (Stratagene, CA).
rRNA operon number determination. The rRNA operon number in the different
ASF strains was determined to enable correlation of copies of the gene to number of bacteria.
Where the ASF strain could be grown in liquid culture and high-quality genomic DNA
extracted (ASF356, ASF360, ASF361 and ASF519), a Southern hybridization-based protocol
for the estimation of operon number was used. 1-2 tg of genomic DNA extracted from the
individual ASF strains was digested overnight with different restriction enzymes (six-cutters
[BamHI, BglII, EcoRI and HindIII] and four-cutters [HhaL and NciI]) that did not have a
recognition site in the probe region. The digested genomic fragments were run for 4-5 h on a
0.7% agarose gel at 5-6 V/cm and then electrophoretically transferred onto a Zeta-probe GT
membrane (BioRad, CA) using the Trans-Blot SD semi-dry transfer cell (BioRad, CA). The
DNA was crosslinked to the membrane in a UV crosslinker (Stratagene, CA). The probe
consisted of a 500-bp fragment of the 16S rRNA from each ASF strain amplified using the
16S rRNA primers 27F and 519R (17) and gel-purified. The probe was labeled by random
priming (Amersham, CA) using [3 2P]dATP (Perkin Elmer Life Sciences, MA).
Unincorporated [32P]dATP was removed by purification with MicroBio-Spin 30 columns
(BioRad, CA). The membrane was hybridized with the probe for 14 h in a hybridization
buffer containing 50% formamide (Amersham, CA), 6X SSC, 5X Denhardt's solution and
sheared salmon sperm DNA (100 tg/ml) (Brinkmann, NY). The membrane was then
subjected to two low-stringency washes for 30 min (in 2X SSC, 0.1 %SDS at 37*C and 1.5X
SSC, 0.1%SDS at 50'C respectively) and one high-stringency wash for 1 h at 65'C (IX SSC,
0.1 %SDS). A phosphor-storage plate was exposed to the membrane for 5-30 min and
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scanned on a Cyclone Phosphor Imager (Perkin Elmer Life Sciences, MA). The amount of
radioactive label in the bands was quantified using Optiquant software (Perkin Elmer Life
Sciences, MA) and a comparison of the number and intensity of the bands for the different
restriction enzymes was used to determine a consensus copy number.
Two of the strains (ASF457 and ASF492) could not be grown in sufficient quantities
for Southern hybridizations. Thus, rRNA operon number was estimated by correlation of
microscopic cell counts with target copy number estimated by QPCR. Cells were collected
from either from a liquid culture or a pure culture on Schaedler agar plates. Cells collected
from plates were resuspended in Schaedler broth. Following vortexing to disrupt any cell
clumps, two replicates of 100 [l were spun down at 8000xg for 10 min and DNA was
extracted from the resultant cell pellet using the DNeasy tissue kit (Qiagen, CA). Two
replicates of 1/100 and 1/50 dilutions of the cell suspension were made in 0.2-ptm-filter
sterilized PBS (pH 7.4), fixed with 100 pl formaldehyde, stained with 4'-6-Diamidine-2'-
phenylindole-dihydrochloride (DAPI) (Sigma, MO) and collected on a Nucleopore
membrane (Millipore, MA). Cell numbers were estimated using an Axioskop epifluorescence
microscope (Carl Zeiss, NY). QPCR was performed on 5 replicates from each of the two cell
pellet samples, using the conditions described above, and the number of copies in the
template were estimated using the average CT numbers. The number of copies from QPCR
was divided by the number of cell-equivalents used as template, as calculated using the cell
counts, to yield an estimate of the operon copy number. The average of the values obtained
for the two replicates is reported as the estimated copy number. The method was tested using
Lactobacillus murinus ASF361, for which the copy number had been estimated using the
Southern hybridization protocol to be 6 copies. The QPCR-based protocol yielded an
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estimate of 5.79 copies, indicating its validity. While the protocol yields an estimate of the
copy number, some error may be present due to the variability in bacterial counts and losses
due to DNA extraction. ASF500 and ASF502 (both most closely related to Clostridium spp.)
did not grow sufficiently on plates to allow the use of even the alternate method. Hence, the
average rRNA operon number of the Clostridium group (11.2) reported on the rRNA operon
number database (16) was used in all calculations of cell numbers.
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RESULTS
Assay development. All primers were sensitive and specific for the strain they were
designed to target. Comparison against Genbank using BLAST (1) produced hits only against
the ASF strains for four of the primer combinations, while the remaining four also hit some
closely-related sequences (2 99% or more sequence similarity) from intestinal clone libraries
(Table 1). Amplification of each ASF strain in a background of fecal pellet DNA resulted in
all cases in only one band of the same size as the strain-specific PCR product. Further,
melting curves obtained for QPCR products amplified from DNA of pure strains, fecal pellet
DNA from RF mice and GI samples were identically shaped for each primer pair. The
products were also sequenced to confirm their identity. All these results indicate the
specificity of the primers for the strain they amplify.
The sensitivity of the primers was determined by QPCR of a dilution series over eight
orders of magnitude of the plasmid standards for each strain. The slope of the standard curve,
which is an indicator of amplification efficiency (a slope of -3.3 = 100% efficiency), was in
the range of -3.3 to -3.77 for most of the ASF strains, except ASF502 which had a slope of
-4.65 ( an efficiency of about 60%) (Table 1). The intercept, which is an estimate of the
threshold cycle for the detection of 1 copy of the target gene, was less than 40 cycles for all
the strains except ASF457 (40.96) and ASF502 (48.25). These considerations give
confidence in the high sensitivity of the assay.
The rRNA operon number of the ASF strains was estimated to enable the correlation
of QPCR results to cell numbers (Table 1). While the operon numbers for most of the ASF
strains were estimated by either Southern hybridization or a QPCR-based method, two of the
ASF strains (ASF500 and ASF502) that were closely related to the Clostridium group did not
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grow to adequate levels for the use of either method. The average operon number of the
Clostridium group from the rRNA operon number database (16) was used for all the
calculations for these strains.
Spatial distribution of ASF flora. The total numbers (mean ± standard deviation) of
the ASF strains varied over several orders of magnitude over the length of the GI tract as
determined by averaging the sum of all ASF strains for the three mice (Fig. IA). The
esophagus harbored about 3.76 x 106 (t 2.54x 106) cells/g while the number fell to about
1.59x 106 (t 1.04x10 6) cells/g in the glandular stomach. Surprisingly, no bacteria were
detected in the non-glandular stomach. The number of bacteria increased in the small
intestine to about 1.26xI07 (t 2.34x 107) cells/g. A sharp increase in numbers was evident at
the ileocecal valve, where total levels climbed to 8.30x10 9 (t 5.47x10 9) cells/g in the cecum
and remained at about 5.78x10 8 (: 4.76x108) cells/g and 1.13x10 9 (t 3.09x10 8) cells/g in the
colon and feces respectively. Overall, the diversity of strains and relative distribution
changed substantially over the GI tract. The aerotolerant anaerobe, Lactobacillus murinus
ASF361 comprised close to 100% of the total cells in the esophagus, about 50% in the
stomach and small intestine and declined to about 0.01% in the cecum and colon. However,
Mouse #3 showed a deviation from the other two mice, with ASF361 accounting for about
0.2% of the total bacteria in the cecum and colon. The anaerobes were generally absent in the
esophagus and some were present at low numbers in the stomach. They, however, increased
sharply over the length of the intestine, from about 50% in the small intestine to about
99.99% in the cecum and colon.
Four of the ASF strains, Clostridium sp. ASF356 (Fig. IB), Flexistipes sp. ASF457
(Fig. IC), Eubacterium plexicaudatum ASF492 (Fig. ID) and low-G+C-content gram
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positive sp. ASF500 (Fig lE), showed a similar distribution over the length of the
gastrointestinal tract in all three mice. These four strains were present at low levels (104- 106
cells/g) in the small intestine and increased sharply at the ileocecal valve (108- 109 cells/g),
sustaining this high level in the colon. Surprisingly, the extremely oxygen sensitive (EOS)
strain ASF500 was also seen at low levels (102- 103 cells/g) in the esophagus of all three
mice. Aerotolerant Lactobacillus murinus ASF361 (Fig. IF) maintained populations of 105 -
107 cells/g over the length of the GI tract of all three mice, with about 106 cells/g in the
esophagus, 104 - 106 cells/g in the stomach, 105 - 107 cells/g in the small intestine and cecum
and falling to lower levels in the colon. The apical cecum (C2) of Mouse #3 had higher levels
of Lactobacillus murinus ASF361 along with lower levels of the other strains when
compared to Mouse #1 and Mouse #2. The other lactobacillus, ASF360, was absent in most
regions of the gut and had very low levels of 102 cells/g when present.
ASF502 (Fig.1G) and ASF519 (Fig. 1H) showed greater variation between the three
mice. The distribution of Bacteroides sp. ASF519 was similar for all three mice in the
stomach (104-105 cells/g), small intestine (105-106 cells/g) and colon (107-109 cells/g). In the
cecum, however, Mouse #2 had much higher numbers as compared to Mouse #1 and Mouse
#3 (108 v/s 104-106 cells/g). The distribution of ASF502 varied between the three mice in the
small intestine. Mouse #3 had higher numbers of ASF502 in the stomach (106 cells/g v/s 14
cells/g) and small intestine (107 cells/g v/s 106 cells/g) as compared to Mouse #1 and Mouse
#2. However, the numbers were comparable for all three mice in the cecum (109 - 1010
cells/g) and colon (107-108 cells/g), with Mouse #1 having lower levels (106 cells/g) at the
ileocecal junction.
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Comparison of fecal and intestinal bacterial distribution. The levels of individual
ASF strains in fecal matter varied over 3 orders of magnitude between different ASF species,
but were similar for all three mice. The non-parametric Kruskal-Wallis test indicated no
significant differences between the fecal distributions for the three mice (P=0.75, KW
statistic = 0.564) and hence the ASF strains had the same population distribution in the feces
of all three mice. ASF502 and ASF519 were present at about 109 cells/g feces while ASF361
and ASF457 were present at about 10' cells/g feces. ASF492 and ASF500 were present at
about 107 cells/g and ASF356 was present at about 106-107 cells/g feces (Fig. 2).
Since fecal bacteria are often used as a surrogate for studying the colonic microbiota,
we compared the levels of the bacteria in feces to levels in the colon. This indicated a
considerable difference in the distribution of the ASF species in the colon and feces. The data
were normalized to make the samples more comparable since per gram values for tissue are
not comparable to feces. The numbers of the different ASF strains in each section of the
colon and in feces was divided by the numbers of Lactobacillus murinus ASF361 in the same
section. The ratios in the different sections were then compared for similarity. The fecal
numbers of the ASF strains were within an order of magnitude of ASF361 numbers.
However, the colonic ratios varied greatly, with Flextipes sp. ASF457, Clostridium sp.
ASF502 and Bacteroides sp. ASF519 present at 2-3 orders of magnitude higher than
ASF361. The other strains were 1-2 orders of magnitude higher in abundance (Table 2).
Thus, there was only poor correspondence between the fecal and colonic levels of the ASF
strains.
Stability of ASF flora in restricted flora mice. PCR with ASF primers of fecal
pellet DNA from C57BL/6 RF mice yielded the correct-sized bands for all the ASF strains
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(Fig. 3). The PCR products were sequenced and found to be identical to the ASF strain
sequences. This demonstrated the persistence of the ASF strains in the GI tract of RF mice,
which have been bred and maintained in an isolator without sterile food, water, or bedding
for 3 years.
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DISCUSSION
Here, we present the ASF defined flora mouse as a model system for the study ofhost-
bacterial and inter-species interactions in the gut. Defined flora models are invaluable in
studying the effects of the microflora on the mammalian host in a manner not limited by the
complexity and mouse-to-mouse variability that the full microbial complement entails (8).
Recent studies have generally utilized the simplest defined flora models, colonized with a
single bacterial species such as Bacteroides thetaiotaomicron (12) and E. coli (13), to assess
the role of the microflora in host development and colonization resistance to Salmonella
infections respectively. However, a more complex but easily quantifiable model system
would be invaluable for many applications. The ASF model may be such a system for several
reasons. First, mice colonized with the ASF strains have normal GI physiology, as shown by
the similarity of their cecal size to normal mice and their resistance to opportunistic
pathogens. Second, the ASF flora is stable. Even when the defined flora mice were
maintained in clean conditions but without sterile food, water, or bedding over several years,
allowing other bacteria to colonize the gut, we detected the ASF strains in the feces of the
mice by PCR methods. Further, a recent study assessing the diversity of the mouse GI
microbiota using clone libraries found several of the ASF strains to be present, indicating that
they are stable members of the complex mouse microbiota (24). Third, ASF mice are widely
available and with the increased routine use of QPCR, the model system is easily accessible.
Since the constituents of the flora were chosen for both historical and functional reasons,
they might not be ideal for all studies. In particular, several of the metabolic groups of
intestinal bacteria are not represented in this model. However, additional bacterial strains can
be added to this model to address various questions of interactions. Further, observations by
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studies using this model can serve as the basis for developing hypotheses to test in mice with
a complex microflora. The choice of mouse strain in our study was influenced by its
availability and prior use to test the pathogenesis of Helicobacter hepaticus in the
development of IBD, in a defined non-pathogenic microbial background (3). Since the mice
lack both T and B cells, they afford some ability to separate the effects of bacterial
interactions from specific immune responses of the host. Thus, they represent a powerful
model for studying the role of the microecology of the gut in the pathogenesis of diseases
such as IBD.
QPCR has proven a robust and sensitive method for the quantification of bacterial species
in complex environmental communities. QPCR assays developed for the quantification of the
different ASF strains are specific for the strains, as shown both by a search against Genbank
using BLAST and by amplifying the strain of interest in a complex background. The assays
performed well in all regions of the GI tract, but the small intestine samples exhibited a high
background. This was likely due to the higher number of mammalian cells, and hence
mammalian DNA, which intercalated the fluorescent dye used to detect and quantify PCR
amplification products. Dilution of these samples prior to the quantification reduced the
problem but led to a higher detection limit (~1045 copies v/s 10'-' copies in other regions) and
higher intra-assay variation (0.08-1.67 CV). Some of the cecal samples also had to be treated
similarly. In contrast, the values obtained in the colon showed low intra-assay variation
(0.04-0.74 CV).
Culture-based methods have previously been used to study the distribution of bacteria in
the different parts of the GI tract. A comparison of total bacterial counts in feces with culture
results indicated that 20-40% of fecal bacteria were culturable by the methods used (18).
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Thus, the culturability of intestinal bacteria is better than other environmental systems, where
the value is typically around 0.01% (2, 14). Culture-based studies in mice (28) and humans
(5) have indicated that the esophagus has about 107 cells/g, the stomach about 10 3-10 9 cells/g,
the small intestine about 105-108 cells/g (predominantly lactobacilli) and the large intestine
about 1010 -1012 cells/g (predominantly anaerobes). These numbers compare favorably with
our results of a total of 106-107 cells/g in the esophagus and stomach, although we did not
detect any bacteria in the non-glandular stomach where the expected number and type of
bacteria would be similar to the esophagus (28). Since the non-glandular stomach lacks a
mucus layer and the bacteria are loosely attached, one of the possible factors leading to this
result could be the loss of bacteria due to the wash that we subjected the stomach to in order
to remove the ingesta. Given that the sensitivity of our assays was of the order of 10
cell/reaction, our lower limit of detection would be about 103 cells/g in the non-glandular
stomach. In the small and large intestine, we observed about 106-108 cells/g and 108-1010
cells/g respectively. Like the culture-based studies, we also observed a sharp thousand-fold
increase in bacterial numbers across the ileocecal valve. Thus, the QPCR-based data
corresponds well with culture-based studies and the ASF strains reach near natural levels in
the defined flora model.
Oxygen sensitivity of the individual ASF strains appears to be a predominant factor in
their distribution along the GI tract and a good proxy for overall community patterns. The
increasingly anaerobic nature of the GI tract from the stomach to the large intestine has
recently been shown in live mice using non-invasive electron paramagnetic resonance (EPR)
methods (9). The esophagus and stomach are aerobic, with a decreasing gradient of oxygen
along the small intestine and the cecum and colon are anaerobic. Based on the results of
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previous culture-based studies (28), the aerotolerant Lactobacillus sp. ASF360 and ASF361
would be expected to have high numbers in the esophagus, stomach and small intestine.
Lactobacillus murinus ASF361 does follow this trend, with high numbers in these regions
(106-108 cells/g wet weight, 100% of esophageal bacteria, about 50% of small intestine
bacteria). These high levels are maintained in the cecum, with a decrease over the length of
the colon (104-107 cells/g wet weight). The anaerobic ASF strains would be expected to have
high numbers in the cecum and colon (>109 cells/g) and low numbers (<105 cells/g)
elsewhere, as seen by culture-based studies (6). Indeed, the distribution of Clostridium sp.
ASF356, Flexistipes sp. ASF457, Eubacterium sp. ASF492, low G+C strain ASF500,
Clostridium sp. ASF502 and Bacteroides sp. ASF 519 follows this trend. There was a
dramatic increase in the populations of the anaerobic ASF strains at the ileocecal valve and
the populations were maintained at high levels of 10 8- 10 10cells/g (wet weight) in the cecum
and colon. Thus, the patterns seen by QPCR correspond well with culture-based studies but
afford higher throughput and accuracy between samples. Furthermore, oxygen sensitivity of
the strains appears to explain the overall distribution of the ASF strains at the current spatial
resolution of the assay.
Factors other than oxygen-sensitivity may also play a role in regulation of population
abundance. Mice are coprophagic and ingestion of fecal matter may cause detection of
transient populations especially in the upper GI tract. This, for example, may explain the low
levels of anaerobic populations (105-107 cells/ g) in the stomach and small intestine of all
mice. However, existence of anaerobic microniches cannot be discounted at this point and
may be a more likely explanation for the presence of ASF500 in the esophagus. This strain is
extremely oxygen sensitive and was the only anaerobe to be present in the esophagus of all
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three mice. Competition due to high niche overlap may explain why one of the lactobacilli
was only present at trace amounts in the gut of all three mice. Lactobacillus sp. ASF360 was
detected only in very low numbers (<103 cells/g wet weight) in a few regions of the GI tract.
However, we were able to detect ASF360 by PCR in fecal pellet samples from C57BL/6 RF
mice (Fig. 3), indicating that it was a stable colonizer of ex-gnotobiotic strains of mice. To
determine this discrepancy and to further differentiate the distribution of the ASF strains,
more detailed studies with finer resolution will need to be performed.
Inter-mouse variation of the total bacterial numbers/g was relatively moderate. Higher
levels of bacteria were seen in the stomach and small intestine of Mouse #3 while the
stomach of Mouse #1 has relatively fewer anaerobic ASF strain than the other two mice.
Fecal matter consumed prior to the dissection is a possible cause for this increase in Mouse
#3, since the levels of bacteria were also high in the stomach. Individual strains showed low
inter-mouse variability over the length of the GI tract, with the exception of Clostridium sp.
ASF502 and Bacteroides sp. ASF519. ASF502 exhibited high inter-mouse variation in the
small intestine, with higher numbers in the small intestine of Mouse #3 as compared to
Mouse #1 and Mouse #2. This mirrored the total bacterial distribution discussed above and
coprophagy is also a likely cause for this difference. ASF519 showed high inter-mouse
variation in the cecum. Mouse #2 had 2-3 orders of magnitude higher levels of ASF519 as
compared to Mouse #1 and Mouse #3. This was confirmed by repeating the quantification.
However, the numbers of ASF519 become comparable for all three mice in the colon.
Overall, the inter-mouse variation is within an order of magnitude and the few differences
that were observed between the three mice could be due to differences in feeding or
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coprophagy. Moreover, the colon, which is often the region of interest in studying the
microecology of the gut, showed little inter-mouse variation for the different ASF strains.
The lack of accessibility of the gut for easy sampling has resulted in the frequent use
of fecal matter as a surrogate for the colonic flora. However, the utility of this approximation
may not be suitable for all purposes, since the qualitative and quantitative correspondence of
the fecal bacterial distribution to the colonic biota has not been studied in detail (23).
Zoetendal et al. (35) provided evidence that the human colonic mucosal flora and fecal flora
are significantly different based on molecular community fingerprints obtained by
Denaturant Gradient Gel Electrophoresis (DGGE). Our study is, to the best of our
knowledge, the first to use quantitative molecular methods to compare the quantitative
distribution of bacteria in fecal matter and the colon. Our results show that even in the
limited diversity of the ASF model, the microflora of the colon is only poorly reflected in
fecal matter. The distribution of ASF strains in feces was similar for all three mice and all the
ASF strains (except ASF360) were present in feces varying within an order of magnitude.
The colonic distribution, however, varied over three orders of magnitude, with anaerobes
exceeding the aerotolerant ASF361 by a thousand-fold. In contrast to this, the levels of
ASF361 in feces were comparable to the levels of the anaerobes. Thus, our results, in
conjunction with the study of Zoetendal et al. (35), suggest that the fecal microflora differs
quantitatively from the colonic microflora and that the fecal flora may be an inappropriate
surrogate for some questions of GI ecology.
The role of the microbiota in the host remains difficult to assess largely due to the
complexity of the gut ecosystem. Thus, the characterization of defined flora mice colonized
with the ASF flora, along with the highly specific and sensitive assays developed for the
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accurate quantification of the ASF, should provide a useful tool for the study of a wide range
of questions in gastrointestinal microecology. Examples of questions that may be addressed
with this model system include population dynamics that drive colonization resistance to
pathogens, understanding the role of the normal microbiota in the prognosis of diseases such
as IBD and the spread of antibiotic resistance.
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FIGURE LEGENDS
FIG. 1. The distribution in different sections of the GI tract of (A) total bacterial cells/g, (B)
ASF356, (C) ASF457, (D) ASF492, (E) ASF500, (F) ASF361, (G) ASF502 and (H)
ASF519, is shown here for the three defined flora C.B-17 mice. Mouse#1 is represented by
solid circles, Mouse#2 by open squares and Mouse#3 by an open diamond. Section El:
esophagus, S 1-2: stomach, 11-6: small intestine, C1-2: ileocecal junction and distal cecum
and L1-3: colon.
FIG. 2. Fecal levels of the ASF strains in three defined flora C.B-17 mice were determined
by QPCR. Mouse#1: white column, Mouse#2: grey column with shading and Mouse#3:
black column.
FIG. 3. Specific PCR products obtained by amplification of fecal DNA extracted from
C57BL/6 restricted flora mice using the ASF-specific primers. These mice, which originally
harbored the defined flora, have been bred and maintained under non-sterile conditions for 3
years. Lanes 1, 10: 100bp ladder, lanes 2-9: RF fecal pellet DNA amplified with ASF356
(417bp), ASF360 (131bp), ASF361 (182bp), ASF457 (95bp), ASF492 (167bp), ASF500
(285bp), ASF502 (427bp), ASF519 (429bp) specific primers (expected size), respectively.
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TABLE 1. Primer sequences, specificity, rRNA copy number and QPCR parameters' for the ASF strains
Strain Species/group Primer" Slope of Intercept of Specificity' Operon
name standard standard number
curve curve
ASF356 Clostridium sp. 356-144F CGGTGACTAATACCGCATACGG (100) -3.50 35.83 NHd 5e
356-538R CCTTGCCGCCTACTCTCCC (100)
ASF360 Lactobacillus 360-81 F CTTCGGTGATGACGCTGG (300) -3.49 37.26 Both primers hit L. intestinalis and 99- 4e
sp. 360-189R GCAATAGCCATGCAGCTATTGTTG (200) 100% identical clones
ASF361 Lactobacillus 361-278F GCAATGATGCGTAGCCGAAC (200) -3.30 32.97 Both primers hit L. animalis and 99- 6e
murinus 361-435R GCACTTTCTTCTCTAACAACAGGG (300) 100% identical clones
ASF457 Flexistipes gp. 457-130F CCGAAAGGTGAGCTAATGCCGG (100) -3.77 40.96 NH 14'
457-219R GGGACGCGAGTCCATCTTTC (100)
ASF492 Eubacterium 492-57F CTGCGGAATTCCTTCGGGG (100) -3.72 38.15 NH 4'
plexicaudaturn 492-204R CCCATACCACCGGAGTTTFC (100)
ASF500 Low-G+C- 500-183F GTCGCATGGCACTGGACATC (200) -3.45 34.52 Reverse primer hits environmental 11.21
content gyram ~t~RCCGTCGCGG.C~clones and human colonic clones0 500-445R CCTCAGGTA CCGTCACTTGCTTC (200) oesadhancoiclns
positive gp.
ASF502 Clostridium sp. 502-195F CGGTACCGCATGGTACAGAGG (200) -4.65 48.25 NH 11.21
502-600R CAATGCAATTCCGGGGTTGG (300)
ASF519 Bacteroides sp. 519-834F CACAGTAAGCGGCACAGCG (200) -3.78 38.57 Forward primer hits uncultured pig GI 5"
519-1243R CCGCTCACACGGTAGCTG (200) and environmental clones, reverse
primer hits identical mouse clone
MgCl concentration used in the QPCR mixtures was 4.0 mM.
The primer designation (F, forward; R, reverse), sequence, and nanomolar concentration of the primer used
in QPCR (in parentheses) are shown.
c Specificity determined by BLAST on I" July, 2003.
d NH = No other hits.
a Estimated using Southern blotting
(Estimated using QPCR , see Materials and Methods.
Average for Clostridium spp. from rRNA Operon Copy Number Database (16).
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TABLE 2. Comparison of the ratiosa of the ASF strains in different section of the colon and in fecal matter.
Llb L2 L3 F1
Strain M#1 M#2 M#3 M#1 M#2 M#3 M#1 M#2 M#3 M#1 M#2 M#3
356 62.4 875.7 54.1 547.6 53.9 46.5 110.6 253.7 142.4 0.1 0.0 0.1
361 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
457 392.5 738.3 84.9 1060.7 213.9 190.7 554.4 4499.1 524.1 0.9 0.7 0.6
492 69.9 966.4 89.9 424.0 10.3 42.5 104.8 113.1 75.5 0.1 0.0 0.3
500 30.1 154.2 7.4 81.0 6.1 8.7 16.7 11.8 8.9 0.3 0.1 0.2
502 675.2 3632.5 130.5 2388.8 209.1 289.1 1022.8 787.6 298.2 7.7 1.2 5.7
519 82.1 324.2 24.6 3597.2 1357.4 296.2 4027.7 2847.9 826.6 11.4 0.8 2.1
" Ratios were obtained by dividing the numbers of the strains in each section by the numbers of ASF361 in the same section
b L1-3: proximal to distal colon, Fl: fecal sample, M#1-3: Mousel-3
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ABSTRACT
The mammalian gastrointestinal tract harbors a complex microflora that is present at levels as
high as 1010-2 cells/g tissue and has hundreds of species of bacteria. The gut microflora has
an important role in the health and development of the host, as well as in causing disease.
Detailed analyses of the role of the microflora in its postulated functions are hindered by the
lack of a representative model system that is also functional. The eight bacterial strains of the
altered Schaedler flora could be one such model system. The validity and utility of the ASF
models system would be further enhanced if the ASF strains were stable in the mouse GI
tract in the face of competition due to other microflora found in different mouse models from
commonly used commerical vendors. This study assessed the prevalence and abundance of
ASF strains in the feces of inbred C.B-17 SCID and outbred Swiss Webster mice from
Taconic, Charles River Laboratories and Harlan. Other than Eubacterium plexicaudatum
ASF492, which is only found in Taconic defined flora C.B-17 SCID mice, all the other ASF
strains were detected in most of the animals assessed. Specific patterns were seen in the
quantitative distribution of Lactobacillus sp. strain ASF360 and Mucispirillum schaedleri
ASF457 in terms of their levels in C.B-17 SCID (higher ASF457, lower ASF360) and Swiss
Webster (lower ASF457, higher ASF360) mice. The total levels of the ASF strains in the
feces of mice with a flora of unknown complexity were as high as 20% of the total levels in
defined flora C.B-17 SCID mice from Taconic. These results indicate that the ASF strains are
detectable in both inbred and outbred mouse models from several vendors and could
potentially be utilized as a universal model system for assessing the microbial ecology of
mice from different vendors.
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BACKGROUND
The gastrointestinal tract of mammals harbors a complex microbial ecosystem with
possibly hundreds of species of bacteria (Moore, 1974, Savage, 1977, Xu, 2003). These
bacteria are present at total levels as high as 101012 cells/gram tissue in the colon and are
thought to outnumber mammalian cells in the human body by an order of magnitude
(Savage, 1977). The microflora are known to playing an important role in the health of the
host by interacting with the host both locally and systemically. The GI tract microflora are
involved with the development of the host immune system and in aiding host nutrition (Falk,
1998, Hooper, 2002). There is also evidence that the complex microbiota acts as an
ecological barrier in preventing pathogens from establishing themselves in the GI tract and
causing disease (Kennedy, 1987, Vollaard, 1994). On the other hand, the GI tract microflora
can also be associated with causing disease in the host, either through opportunistic
pathogenesis (Falk, 1998), or by being one of the factors triggering an uncontrolled
inflammatory response (Bouma, 2003). Due to these multiple positive and negative effects,
different aspects of the GI microflora interaction with the mammalian host have been the
focus of study for several decades.
There are several obstacles to studying the role of the GI tract microflora in
mammalian health and development. Over 99% of the bacterial species in the GI tract are
obligate anaerobes that are difficult to culture (Savage, 1977, Berg, 1996). Further, the high
level of diversity renders the study of the microflora by traditional culture-based, as well as
molecular biological methods difficult. In addition, non-destructive sampling of the intestinal
tract is cumbersome. This has necessitated the use of several different model systems to
study the role of the intestinal microflora in the host, as well as the changes in bacterial
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populations in the GI tract in response to different factors (Rumney, 1992). Both in vitro
models, where the intestinal bacteria interact in a laboratory setup, and in vivo models
involving animal species have been used to study the role of the intestinal microflora. Some
of the most commonly used in vitro model systems include continuous flow reactors
incubated with either specific members of the intestinal flora or the entire fecal flora
(Rumney, 1992). Such models have been used to study the ecology and metabolism of the
colonic microflora (Macfarlane, 1998). Chemostats have yielded interesting insights into the
reduction in population levels of specific bacterial strains in the presence of other intestinal
bacterial strains (Freter, 1983). However, the GI tract is spatially diverse with structured
microenvironments whereas chemostats are homogeneous environments. Further, although
bacterial interactions are important, it is in the context of the host that the effect of these
interactions often needs to be assessed. This has led to the use of in vivo models in order to
dissect the host effects of the GI microflora. These models typically involve small animals
colonized with known bacterial components or with the entire complex microbiota. The most
common species of animals used are mice (Rumney, 1992), rats (Rath, 2002), ferrets (Marini,
2004) and pigs (Leser, 2002), although other models such as zebrafish are increasingly being
used (Rawls, 2004).
Mouse models have been especially useful in helping to understand the role of the
intestinal microflora. One factor driving this use is the availability of genetically engineered
mouse models used to study the immune system. These models can help elucidate the
interactions between the microflora and the host immune system. Another important
advantage of small animal models is the ability to derive and maintain them germfree, as
germfree animals can be colonized with specific bacterial strains to study a variety of roles of
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the intestinal bacteria (Gordon, 1971, Falk, 1998). Studies have shown that germfree mice
associated with a single commensal bacterial species have a markedly different
transcriptional profile in the intestine (Hooper, 2001) and are less susceptible to infection by
pathogens (Hudault, 2001) when compared to germfree mice.
While germfree mice inoculated with a single bacterial strain provide information on
host effects, the gut ecosystem in reality consists of several interacting microbes. Thus, a
more complex functional flora would complement information derived from mono-
associated mouse models and provide a deeper understanding of ecological effects observed
in animals maintained in a barrier or conventional state. One such model system is the
Altered Schaedler Flora (ASF) that consists of eight bacterial strains that are representative
of the composition of the complex microflora (Dewhirst, 1999). The original Schaedler flora
was selected in 1965 from among several autochthonous isolates of bacteria from the GI
tracts of mice, with the purpose of colonizing germfree mice to protect them from
opportunistic infections. This set of organisms, however, consisted primarily of aerobic and
aerotolerant bacterial species. The composition of the strains was later modified in order to
make them more representative of the predominantly anaerobic nature of the GI tract
microflora (Orcutt, 1987). The eight strains of the ASF are Lactobacillus murinus strain
ASF361, Lactobacillus sp. strain ASF360, Clostridium sp. strain ASF356, Clostridium sp.
strain ASF500, Clostridium sp. strain ASF502, Eubacterium plexicaudatum strain ASF492,
Bacteroides sp. strain ASF519 and Mucispirillum schaedleri strain ASF457 (Dewhirst, 1999,
Robertson, in press).
Detailed bacterial population analyses of the ASF strains are especially tractable due
to the development of culture-independent molecular methods that sensitively and
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specifically quantify each ASF strain (Sarma-Rupavtarm, Chapter 2). If these strains were
prevalent at high levels in laboratory mouse models, the ASF strains could serve as a
universal model flora in determining changes to the GI tract ecosystem following different
insults. Although major vendors used these strains to colonize their breeding stocks of mice
(Orcutt, 1987), the mice are often not maintained under strict barrier conditions and the
stability of the ASF strains in the face of a challenge by other enteric organisms is not well
characterized. Clone library studies assessing the diversity of the mouse GI microflora have
observed the presence of individual ASF strains (Salzman, 2001, Schuppler, 2004). However,
no study has systematically assessed the prevalence of the ASF strains in the GI tracts of
mice from different vendors.
The overall goal of this study was to evaluate the prevalence of the ASF strains in the
fecal flora of both inbred immunodeficient C.B-17 SCID and outbred Swiss Webster mice
from three different vendors. The specific aims of the study are to 1) assess which of the ASF
strains were present in the GI tracts of mice from the vendors, and 2) enumerate the levels of
individual ASF strains to compare their abundance.
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MATERIALS AND METHODS
Mice. 4 to 6-week old female C.B-17 SCID (inbred) (n=2) and Swiss Webster
(outbred) (n=2) mice were ordered from Taconic (Germantown, NY), Charles River
Laboratories (Wilmington, MA) and Harlan (Indianapolis, IN). The C.B-17 SCID mice from
Taconic had a defined flora while all other mice harbored a flora of unknown complexity.
The mice were euthanatised the same day they arrived at the facility. All mice were
maintained and handled as per MIT IACUC guidelines.
Samples. Mice were euthanatized by CO2 asphyxiation and their entire
gastrointestinal tract was collected aseptically. One formed fecal pellet was collected from
the distal colon. The cecum was divided into the apical region and the ileocecal valve and 0.5
cm sections were collected from the two regions. Also, 0.5 cm sections were collected from
the proximal colon and the distal colon. All samples were weighed and stored at -80'C.
Fecal pellets were used for DNA extraction while the other samples were stored for future
use.
Fecal pellet DNA extraction. A modified bead-beating protocol as described
previously is used (Sarma-Rupavtarm, Chapter 2). Briefly, the fecal pellet was resuspended
by vortexing in Phosphate Buffer Saline (pH 7.4). Tris-saturated phenol (pH 7.4) (500[l),
0.1mm Zirconium beads (0.5g) and 20% Sodium Dodecyl Sulfate (50[l) were added to the
tube and shaken at 5000 rpm for 2 min on a Bead beater (Biospec, OK). After a 10 min
incubation at 60'C, the bead-beating step was repeated. The supernatant was then transferred
to a new tube and an equal volume of phenol-chloroform-isoamyl alcohol (25:24:1) was
added. The tube was mixed by inversion and centrifuged for 5 min at 12000xg. The
supernatant was transferred to a new tube and the same procedure was repeated twice.
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Following this, an equal volume of chloroform (Sigma, MO) was added to the aqueous
phase, the tube was mixed by inversion and centrifuged at 12000xg for 5 min. DNA from the
supernatant was then precipitated using 0.1 volume of 3M Sodium acetate and a volume of
isopropanol equal to that of the aqueous phase. The DNA was pelleted by centrifugation at
15000xg for 10 min, washed with 70% ethanol, dried under a vacuum using a SpeedVac
(Thermo Corporation, MA) and resuspended in Tris-chloride buffer. Losses in extraction of
different samples were kept constant by using constant volumes at all the steps.
QPCR. Primers specific for each ASF strain and reaction conditions for QPCR have
been described previously (TABLE 1). All reactions were performed in triplicate on the
DNA Engine Opticon Continuous Fluorescence Detection System (Bio-Rad Labs, MA) in a
25 [i reaction volume. The MgCl2 concentration was kept constant at 4 mM in all reactions,
as previously optimized (Sarma-Rupavtarm, Chapter 2). The reaction conditions were as
follows: 95*C 10 min, 40 cycles of: 95'C 30 sec, 60*C 45 sec, 72'C 75 sec. Melting curves
were generated post-QPCR to test for purity by identification of the characteristic melting
peak. This was done by measuring the fluorescence of the amplification product every 0.1 C
while increasing the temperature from 50*C to 95'C. Standard curves for individual ASF
strains were generated using a ten-fold dilution series of the linearized plasmid standard
ranging from 1-108 copies. The fluorescence level for determining the threshold cycle (CT)
was set at 0.01 fluorescence units in all reactions. Fecal pellet DNA was diluted 1 in 5 prior
to use in QPCR to prevent the effects of any inhibitory substances in the extracted DNA.
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RESULTS
Prevalence of ASF strains in fecal matter of mice from different vendors. Most of
the ASF strains were detected in both C.B-17 SCID and Swiss mice from Taconic, Harlan
and Charles River Laboratories (CRL) (TABLE 2). The most noticeable difference was in the
distribution of Eubacterium plexicaudatum strain ASF492, which was detectable only in
Taconic C.B-17 SCID mice. On the other hand, Lactobacillus sp. strain ASF360 was
detectable in all the mice assessed except for Taconic C.B-17 SCID mice. Bacteroides sp.
strain ASF519 was present in all the mice except Harlan Swiss mice. Clostridium sp. strain
ASF356, Lactobacillus murinus strain ASF361, Mucispirillum schaedleri strain ASF 457,
Clostridium sp. strain ASF500 and Clostridium sp. strain ASF502 were present in both
mouse backgrounds from all three vendors.
Total levels of ASF strains in mice from different vendors. Cumulative levels per
gram feces wet weight of the ASF strains varied over an order of magnitude between the
different strains of mice. Levels of the ASF strains were highest in Taconic C.B-17 SCID
mice, which are maintained under strict gnotobiotic conditions by the vendor, at 6.6 x 100
cells/g wet weight feces. Since the eight ASF strains are the only bacteria present in the GI
tract of the Taconic SCID mice, the total bacteria/g feces in these mice could be thought of as
the maximum population level that the ASF strains can reach in the feces of mice. When the
total levels/g feces wet weight of ASF strains were expressed as a percentage of the levels in
Taconic SCID mice, the values ranged from a low of 8.16% in Taconic Swiss Webster mice
to a high of 20.57% for CRL Swiss Webster mice (Figure 1). The total levels of the ASF
strains in CRL and Harlan Swiss Webster mice, when expressed as a percentage of Taconic
SCID levels, were seen to be higher than the levels in CRL and Harlan SCID levels. A major
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contributor to these differences is the fact that Lactobacillus sp. strain ASF360 is present at
levels 3-4 orders of magnitude higher in Swiss Webster mice than in SCID mice.
Quantitative distribution of ASF strains in C.B-17 SCID v/s Swiss Webster Mice.
There was a high level of variation in the numbers of the specific ASF strains in the feces of
mice when compared across different backgrounds and vendors (Figure 2, A-C).
Lactobacillus sp. strain ASF360 was seen to be present at levels 2-3 orders of magnitude
higher in Swiss mice than in SCID mice from all vendors, while Mucispirillum schaedleri
strain ASF457 was consistently present at levels 1-2 orders of magnitude higher in SCID
mice as compared to Swiss mice from all vendors. In contrast to this, no specific patterns
were seen in the distribution of Clostridium sp. strain ASF356, Clostridium sp. strain
ASF500, Clostridium sp. strain ASF502, Lactobacillus murinus strain ASF361 and
Bacteroides sp. strain ASF519 between SCID and Swiss mice from the same vendor.
Lactobacillus murinus strain ASF361 and Bacteroides sp. strain ASF519 were present at
high levels (> 108 cells/g feces wet weight) irrespective of vendor or background.
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DISCUSSION
We present an assessment of the stability of the eight bacterial strains of the altered
Schaedler flora in the mouse gastrointestinal tract flora of both inbred C.B-17 SCID mice and
outbred Swiss Webster mice from three different vendors, viz. Taconic, Harlan and Charles
River Laboratories (CRL). The altered Schaedler flora consists of bacterial strains that were
isolated from the GI tracts of laboratory mice and are believed to be autochthonous members
of the mouse GI flora (Orcutt, 1987, Dewhirst, 1999, Macpherson, 2004). Several vendors
used the ASF strains to colonize their barrier-maintained breeding stocks, but the production
stocks are not maintained under barrier conditions, leaving them susceptible to acquiring
other bacterial strains from food, water, animal care workers and the environment. Of the
three vendors used in this study, Taconic maintains its production stock C.B-17 SCID mice
under strict barrier conditions and hence, the mice are known to be defined-flora, harboring
only the ASF strains. The Swiss Webster mice from Taconic are not maintained in isolators
and expected to have other non-pathogenic bacteria. Charles River Laboratories does not
maintain its production stock of C.B-17 SCID mice in isolators and only checks them for
pathogens. The same is true for the Swiss Webster mice from CRL. Harlan does not specify
the conditions under which it maintains its production stocks of mice.
Most of the ASF strains were detected in both C.B-17 SCID and Swiss Webster mice
from all three vendors. The strains present in all mice tested are Clostridium sp. strain
ASF356, Clostridium sp. strains ASF500 and ASF502, Lactobacillus murinus strain ASF361
and Mucispirillum schaedleri strain ASF457. Bacteroides sp. strain ASF519 was present in
all mice tested except for Swiss Webster mice from Harlan. These findings are consistent
with a recent clone library assessment of the microflora of FvB and C57/B6 mice that found
ASF360, ASF361, ASF502 and ASF519 among the clones screened (Salzman, 2002).
Some of the ASF strains showed interesting patterns in their distribution in different
mouse models. Eubacterium plexicaudatum strain ASF492 was found only in defined-flora
SCID mice from Taconic and was absent in the other mice tested. This could indicate that
ASF492 is not truly autochthonous and is easily displaced when challenged by other
incoming bacterial species. On the other hand, Lactobacillus sp. strain ASF360 was present
in all mice tested except the defined-flora C.B-17 SCID mice from Taconic. This finding is
surprising, as it would be expected that a bacterial strain that is unable to colonize in a simple
defined-flora background would be easily out-competed in the presence of other bacterial
species. It is unlikely that the immunodeficiency of C.B-17 SCID mice is responsible for the
absence of this strain, as the C.B-17 SCID mice from Harlan and CRL harbor ASF360, albeit
at relatively low levels (Figure 1 B, C). One possible explanation for this observation is that
ASF360 is inhibited in the presence of some component of the ASF strains and the
introduction of additional species of bacteria suppresses this competitor, allowing for the
persistent colonization of ASF360. Since ASF360 and ASF492 are not both detectable in the
same mouse sample, the possibility exists that ASF360 is suppressed by ASF492 in defined
flora mice. Further experiments that assess the possibility of competition between these two
strains in germfree mice could provide more information on this possible explanation.
Another possibility is that multiple strains of lactobacilli have the same 16S rRNA sequence
that is targeted by the primers specific for ASF360, and colonization capabilities differ
between these strains. This hypothesis can be tested by isolating the lactobacilli from the
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different mice on selective media and analyzing the biochemical and genetic differences
between the isolates that have the 16S rRNA sequence as ASF360.
The total levels of ASF strains in the different non-defined-flora mouse backgrounds
from the different vendors were less than the total levels in defined-flora C.B-17 SCID mice
from Taconic. Since the defined-flora SCID mice harbored only the eight ASF strains, it
would be expected that the total levels of bacteria in the feces of these mice would be similar
to the maximum possible bacterial levels in feces. Based on this assumption, the levels of
total ASF strains in the non-defined-flora mice were calculated as a percentage of the
defined-flora levels, and indicated that the ASF strains represented between 6.35-20.57% of
the approximate total bacterial levels. This indicates that the ASF strains represent a sizeable
portion of the total fecal bacteria, despite competition from other strains acquired. Typically,
bacterial strains acquired from the environment are aerobic and would not be expected to
constitute a significant proportion of the GI tract microflora.
The quantitative distribution of the different ASF strains in the mice tested varied
widely depending on the strain, background and vendor, but was similar in the two mice of
the same genetic background from the same vendor. Consistent differences in ASF strain
abundance depending on the genetic background of the mice were observed for Lactobacillus
sp. strain ASF360 and Mucispirillum schaedleri ASF457. ASF360 was present at 3-4 orders
of magnitude higher levels in outbred Swiss Webster mice than in C.B-17 SCID mice from
both CRL and Harlan mice. ASF457, on the other hand, was present at 1-2 orders of
magnitude higher levels in C.B-17 SCID mice than in Swiss Webster mice. It has been seen
that ASF457 is present at high levels in the mucus layer of C.B-17 SCID mice (Sarma-
Rupavtarm, Chapter 4) and possible explanations for the lower levels include a functional
immune system in Swiss Webster mice and the potential presence of competing species that
colonize the mucus layer and suppress the levels of ASF457. The levels of the other ASF
strains were similar within an order of magnitude between the different mice tested.
Given the representative nature of the composition of the ASF strains vis-h-vis the
complex microflora, the detection of seven of the eight ASF strains in the GI tract of h inbred
and out-bred mice from several vendors further validates the use of the ASF strains as a
model system. Further, these strains are often present at high levels and can represent a
significant portion of the total bacteria in feces. Also, studying the changes in ASF strain
levels can provide insight into the microecology of the GI tract in diseases. We believe that
the ASF strains can be used as an indicator flora to study changes in the overall GI tract
microbiota even in mice that do not harbor a defined-flora. Another potential significance of
our results is in the use of the ASF strains to standardize the background microflora between
different groups of mice of the same genetic background for use in infection studies, as well
as between different stocks of mice used in replicate experiments. While other approaches
such as a comprehensive 16S rRNA-based phylochip to assess the diversity of the mouse GI
tract microflora are being developed (Wilson, 2002), the accessibility and cost-effectiveness
of PCR and, increasingly, QPCR makes the monitoring of the ASF strains as an indicator
flora very attractive and approachable.
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FIGURE LEGENDS
Figure 1. The relative proportion of the total fecal levels of the ASF strains in
different mouse models are expressed as a percentage of the total fecal levels of the ASF
strains in defined flora C.B-17 SCID mice.
Figure 2. Fecal levels of the different ASF strains in C.B-17 SCID and Swiss Webster mice
from a)Taconic, b) Harlan and c) Charles River Laboratories. 356: Clostridium sp. ASF356,
361: Lactobacillus murinus ASF361, 457: Mucispirillum schaedleri ASF457, 492:
Eubacterium plexicaudatum ASF492, 500: Clostridium sp. ASF500, 502: Clostridium sp.
ASF502 and 519: Bacteroides sp. ASF519.
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TABLE 1. Primer sequences and QPCR parametersa used in the study.
Strain name Forward and reverse primers (concentration used in QPCR
Species/group reaction, nM)
Clostridium sp. ASF356 356-144F CGGTGACTAATACCGCATACGG (100)
356-538R CCTTGCCGCCTACTCTCCC (100)
Lactobacillus sp. ASF360
Lactobacillus murinus ASF361
Flexistipes gp. ASF457
Eubacterium plexicaudatum
ASF492
Low-G+C-content gram positive
gp. ASF500
Clostridium sp. ASF502
Bacteroides sp. ASF519
360-8 IF CTTCGGTGATGACGCTGG (300)
360-189R GCAATAGCCATGCAGCTATTGTTG (200)
361-278F GCAATGATGCGTAGCCGAAC (200)
361-435R GCACTTTCTTCTCTAACAACAGGG (300)
457-130F CCGAAAGGTGAGCTAATGCCGG (100)
457-219R GGGACGCGAGTCCATCTTTC (100)
492-57F CTGCGGAATTCCTTCGGGG (100)
492-204R CCCATACCACCGGAGTTTTC (100)
500-183F GTCGCATGGCACTGGACATC (200)
500-445R CCTCAGGTACCGTCACTTGCTTC (200)
502-195F CGGTACCGCATGGTACAGAGG (200)
502-600R CAATGCAATTCCGGGGTTGG (300)
519-834F CACAGTAAGCGGCACAGCG (200)
519-1243R CCGCTCACACGGTAGCTG (200)
a MgCl2 concentration was 4 mM in all reactions, as optimized in Sarma-Rupavtarm, Chapter 2
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TABLE 2. Prevalence of ASF strains in mice from different vendorsc
Species Charles River Harlan Sprague Taconic
Labs Dawley
SCIDa SWb SCID SW SCID SW
Clostridium sp. strain ASF356 + + + + + +
Lactobacillus sp. strain ASF360
Lactobacillus murinus strain ASF361
Mucispirillum schaedleri strain
ASF457
+ +
+ +
+ +
Eubacterium plexicaudatum strain -
ASF492
Clostridium sp. strain ASF500 +
Clostridium sp. strain ASF500 +
Bacteroides sp. strain ASF519 +
a C.B-17 SCID mice (inbred)
b Swiss Webster mice (outbred)
C as assessed by QPCR, detection limit -5000 cells/g feces
+
+
+
+ +
+ + +
+ + +
+
+
+
+
+
+
+ + +
+ + +
+ + +
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Chapter 4
Bulk and microscale effects of infection by an intestinal pathogen
on a defined microbiota in the GI tract of mice
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ABSTRACT
The mammalian gastrointestinal microbiota is a complex ecosystem, with effects in
the well-being of the host, as well as in causing disease. The role of the microbiota in the
development and nutrition of the host is increasingly being characterized. An important
function of the GI microbiota is in its ability to prevent infections by limiting the ability of
exogenous pathogens to colonize and cause disease through a phenomenon termed
colonization resistance. While in-depth study of microbiota-pathogen interactions such as
colonization resistance has been difficult due to the complexity of the microbiota, the recent
characterization of a defined flora model system involving C.B-17 SCID mice colonized with
the eight bacterial strains of the altered Schaedler flora provides a useful tool for in-depth
ecological studies in the GI tract. This study aims to explore the ecology of infection of an
intestinal pathogen, Citrobacter rodentium in the defined flora C.B-17 SCID mouse model,
with the goal of studying overall population levels, as well as the microscale spatial
localization of the ASF strains and the pathogen in the large intestine using quantitative PCR
and fluorescence in situ hybridization respectively. The population dynamics of C. rodentium
infection were accelerated as compared to the results of prior studies in literature. Infection
by C. rodentium caused changes in the levels of specific ASF strains at early time points
post-infection. Surprisingly, levels of the individual ASF strains and total bacterial levels
were higher in infected mice than control mice. The ASF strains assessed by FISH primarily
localized either in mucus (Mucispirillum schaedleri ASF457), at the lumen-mucus interface
(clostridial strains ASF356 and ASF500) or in the lumen (Bacteroides sp. ASF519). The
localization of the ASF strains was similar in both infected and control mice, with the two
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most abundant bacterial strains, ASF457 and ASF519, being present in dominant in different
spatial niches.
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BACKGROUND
The mammalian gastrointestinal (GI) tract is a complex ecosystem with considerable
variation in environmental conditions. There are marked differences in the physiochemical
characteristics of the GI tract both longitudinally and across. Longitudinally, there is
variation in the oxygen tension, which decreases from the ileum to the colon (He, 1999). The
flow rate of the digesta and the water content are also higher in the small intestine than in the
colon. In addition, the rate of epithelial cell shedding is ten times higher in the small intestine
than in the large intestine (Xu, 2003). Across the cross-section of the intestine, the main
difference in conditions is between the lumen and the mucosal layer. In the lumen, bacterial
cells are susceptible to being removed from the system along with the digestive bolus as it
moves through the GI tract due to peristalsis. The bacterial cells in the mucosal layer, being
either embedded in the layer or attached to it, are relatively protected from removal by
peristalsis but are exposed to the mucosal immune system, as well as removal by epithelial
shedding (Savage, 1977).
The number of bacterial species that could be supported by such a complex
ecosystem is vast. Indeed, there is no accurate estimate of the number of species of bacteria
in the mammalian GI tract, with values in literature ranging from 400 to 1000 (Moore, 1974,
Gordon, 2003). Further, total bacterial numbers are as high as 1010-" cells/g colonic tissue,
with the number of bacterial cells in mammals thought to exceed the number of mammalian
cells by an order of magnitude (Savage, 1977). The bacteria in the GI tract are important to
the health and development of the host. The bacterial role in aiding mammalian nutrition
(Savage, 1986) and the development of the immune system (Hooper, 2001) is increasingly
the focus of attention.
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An important potential role of the bacteria in the GI tract is the ecological barrier they
represent to the establishment of pathogens, both opportunistic and constitutive. The GI tract
is second only to the respiratory tract in terms of the surface area exposed to external
influences (Bengmark, 1998), with exogenous organisms constantly entering the GI tract via
food and water. In the absence of factors preventing their persistent colonization, exogenous
bacteria would be expected to establish themselves in the ecologically diverse GI tract.
However, despite the constant influx of exogenous organisms, the microflora of adult
humans has been seen to be stable over a period of as long as 6 months in the absence of
major dietary shifts (Zoetendal, 1998, Zoetendal, 2003).
The intact intestinal microbiota, in combination with host factors such as GI motility
and mucosal immunity, seemingly forms a barrier that limits exogenous pathogens and
endogenous opportunistic pathogens such as Clostridium difficile that overgrow and cause
disease when the equilibrium of the flora is disrupted. This concept has been termed
"colonization resistance" and the role of the microbiota in effecting the resistance is not well
characterized. Differences in complexity of the microbiota influence the susceptibility of the
host to infections and the extent of disease caused. Following infection by intestinal
pathogens, germfree mice suffered higher mortality rates and had lower LDO values than
mono-associated or defined flora mice (Huduault, 2001, Wells, 1982). Infection by Candida
albicans in antibiotic-treated hamsters, presumably bearing a simpler microflora, predisposed
the hamsters to overgrowth and systemic dissemination of the pathogen (Kennedy, 1986).
Antibiotic-treated mice also showed higher mortality than conventional mice when infected
with intestinal pathogens (Hentges, 1986). One recent study examined the role of
colonization by Bacteroides vulgatus in germfree mice in protecting the mice from colitis
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caused by E. coli mpk (Waidmann, 2003). While B. vulgatus prevented colitis, it was seen
that E. coli numbers and spatial localization in situ were not affected due to the presence of
B. vulgatus. These studies indicate a role for the complex microflora in colonization
resistance and ameliorating the severity of disease.
Studies on mechanisms behind colonization resistance are hindered by the complexity
of the microflora, which makes it difficult to observe and interpret any interactions between
microbes by both culture based and molecular biological methods. Over 60% of the hundreds
of species of bacteria in the GI tract are not culturable by current methods used and greater
than 99.99% of the GI tract bacterial cells are obligate anaerobes (Suau, 1999, Berg, 1996).
Complex model systems, such as antibiotic treated mammals, have been used in the past for
gastrointestinal microbial studies, providing valuable insight into the role of the resident flora
in preventing infection (Hentges, 1986, Kennedy, 1986), but exhaustive studies of
interactions are not possible due to the complexity. Hence, detailed ecological studies on the
interaction between a pathogen and the intestinal flora have been limited to simple models
systems such as mono-associated mice (Waidmann, 2003) or cell culture studies wherein
colonization of a Caco2 cell monolayer surface by commensal strains is seen to exclude
pathogens (Bernet, 1993, Resta-Lenert, 2003). However, such models have the disadvantage
of being functionally different from the complex GI tract microbiota. A simple defined flora
model system that is functional and replicates the composition of the GI tract flora would
ideally complement studies in mono-associated and complex systems. One such functional
model system is the group of eight bacteria called the altered Schaedler flora, whose
members were isolated from mice and are thought to be autochthonous species (Orcutt, 1987,
Sarma-Rupavtarm, Chapter 2 and 3). The flora, as characterized on the basis of the 16S
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rRNA gene sequence, consists of clostridia (strains ASF 356, ASF 500 and ASF502),
lactobacilli (strains ASF360 and ASF361), Eubacterium plexicaudatum strain ASF492,
Mucispirillum schaedleri strain ASF457 (previous thought to be a Flexistipes sp., FOX
paper) and Bacteroides sp. strain ASF519 (Dewhirst, 1999). Molecular methods for the
sensitive and specific quantitation of the ASF strains have been developed and the
distribution of the bacteria along the GI tract has been characterized (Sarma-Rupavtarm,
Chapter 2). The phylogenetic characterization of the strains enables the development of
fluorescence in situ hybridization methods to assess the microscale spatial localization of the
bacterial community across the cross-section of the GI tract.
The overall objective of this study is to explore whether infection by a colonic
pathogen leads to spatial interactions and competition for space between the pathogen and
the host microflora, potentially resulting in changes in the bulk population levels and/or
differences in localization across the luminal-mucosal interface. Since the adult GI tract
ecosystem is a mostly stable community varying mainly with diet and age, competition for
adhesion sites with a successful invading species would be expected to displace the resident
bacteria from their spatial niche, leading to higher potential for washout and hence, lower
population sizes post-infection. Competition for adherence sites has been proposed as a
hypothesis for the mechanism behind colonization resistance (Kennedy, 1987, Vollaard,
1994, Savage, 1978, Hopkins, 2003). The goal of this study is to shed light on potential
mechanisms by which the intestinal microbiota cause colonization resistance. In the study,
immunodeficient defined flora C.B-17 SCID mice harboring the altered Schaedler flora were
infected with the mouse pathogen, C. rodentium. Since the mice lack both B and T cells, their
use in the study provides some ability to separate the effects of pathogen-host microflora
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interactions from specific immune responses of the host. Further, the C.B-17 SCID mouse
model colonized with ASF strains has been previously characterized and validated as a close
approximation of mice harboring a complex flora (Sarma-Rupavtarm, Chapter 2). The mouse
pathogen Citrobacter rodentium is used in the study since it causes mild pathology and has a
short time course of infection. C. rodentium causes disease by attachment and effacement of
epithelial cells, similar to human enteropathogenic E. coli infections, (Nataro, 1998). This
mechanism, as opposed to the toxinogenic infections caused by pathogens such as
Clostridium difficile, provides an opportunity to evaluate any possible pathogen-intestinal
flora competition for adherence sites.
The population levels and spatial distribution of the different ASF strains and C.
rodentium were studied at different time points post-infection. The chief goals of this study
are to 1) assess the variation in the bulk numbers/g of tissue of C. rodentium and the ASF
strains in different regions of the large intestine over several time points in infected and
control mice, and 2) assess the microscale spatial localization of the bacterial community
across the GI tract cross section in infected and control mice.
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METHODS
Bacterial strains: Citrobacter rodentium DBS 120 kanr was grown overnight in LB
broth supplemented with kanamycin. Bacterial concentration was determined by measuring
absorbance at 600 nm. Cells were pelleted by centrifugation and resuspended in autoclaved
water to a concentration of 109 cells/ ml for inoculation in mice.
Mice: Six-week old female C.B-17 SCID mice harboring a defined flora were
ordered from Taconic (Germantown, NY). Isolator cubes (CRL, MA) were cold-sterilized
with Clidox and the mice were housed in them for 72 hours prior to the experiment in order
to acclimatize them to the surroundings and remove the effect of transportation stress on the
experiment. Air entering the isolator cubes was filtered through HEPA filters. Autoclaved
food and water were supplied to the mice during the course of the experiment and handling
of the mice was performed under a sterile laminar flow hood. Instruments were autoclaved
prior to use used in the experiment. Surfaces were decontaminated with Quatricide during
animal handling.
Mice were divided into the experimental group (n= 20) and the control group (n =12).
Isolators housing the experimental group to be infected with C. rodentium were located in a
quarantine facility while those housing the control group were housed in the cleanest facility.
This was done to prevent any potential contamination of mouse stocks with C. rodentium in
the clean facility. In order to minimize the chances of contamination during cage changing,
mice were house at a maximum of 3 per cage (for the experimental groups to be euthanized
on Days 3, 6 and 14 PI) and mice to be euthanized on Day 21 PI were housed singly. Cage
changes were kept to a minimum. All husbandry and experimentation was performed as per
protocols approved by the MIT Institutional Animal Care and Use Committee.
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Oral infection of mice: Mice in the experimental group were intragastrically
inoculated with 100 tl of autoclaved water containing 108 cells of C. rodentium DBS 120
suspension while mice in the control group received 100 tl of autoclaved water. Inoculum
dosage was confirmed by plating dilutions on LB-kan plates.
Sample collection: Mice from the control and infected group were euthanized at the
specified time points by CO 2 asphyxiation. The GI tract from the ileum to the rectum was
excised and samples were collected from the ileocecal valve, proximal colon and distal
colon. Each sample consisted of 1 cm of tissue as measured along the longitudinal axis, of
which 0.5 cm was collected for DNA extraction and the remaining 0.5cm was embedded in
disposable plastic cassettes with OCT (Tissue-Tek) for hybridization studies using
fluorescent probes. The sections in OCT were flash-frozen in liquid nitrogen immediately
after collection. Care was taken to exclude any formed fecal matter from the tissue samples.
Formed fecal pellets were collected from the colon of the mice for DNA extraction.
Instruments were heat-sterilized prior to use for each sample and control mice were dissected
prior to the infected group to prevent any contamination. Tissue and fecal samples were
weighed and stored at -80*C prior to use for DNA extraction.
DNA extraction: (i) Tissue samples. DNA was extracted from tissue samples with
the DNEasy Tissue kit, using a modification of the DNEasy tissue extraction protocol
(Qiagen, CA) to ensure maximal lysis of both Gram-positive and Gram-negative bacteria, as
previous detailed (Sarma-Rupavtarm, Chapter 2). Briefly, following overnight digestion of
tissue samples with proteinase K (20[d, 12mAU) and buffer ATL (Qiagen, CA), the sample
was centrifuged and separated into supernatant and pellet. The supernatant was RNase
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treated and DNA was extracted using the Qiagen DNEasy protocol for tissues. The pellet
from the centrifugation of the lysed tissue was subjected to an extraction using the DNEasy
protocol for Gram-positive bacteria, to ensure recovery of any possibly recalcitrant Gram-
positive bacteria. DNA from both the extractions was pooled and stored at -80*C prior to use
for quantitative PCR.
(ii) Fecal pellet samples DNA was extracted from fecal pellets as previously detailed
(Sarma-Rupavtarm, Chapter 2). Briefly, the fecal pellet samples were resuspended in
Phosphate Buffer Saline (pH 7.4). Tris-saturated phenol (pH 7.4) (500l), 0.1mm Zirconium
beads (0.5g) and 20% Sodium Dodecyl Sulfate (50 tl) were added to the tube and shaken at
5000 rpm for 2 min on a Bead beater (Biospec, OK). After a 10 min incubation at 60'C, the
bead-beating step was repeated following which the supernatant was transferred to a new
tube and an equal volume of phenol-chloroform-isoamyl alcohol (25:24:1) was added. The
tube was mixed by inversion and centrifuged for 5 min at 12000xg. The supernatant was
transferred to a new tube and the same procedure was repeated twice. Following this, an
equal volume of chloroform (Sigma, MO) was added to the aqueous phase, the tube was
mixed by inversion and centrifuged at 12000xg for 5 min. DNA from the supernatant was
then precipitated using 0.1 volume of 3M Sodium acetate and a volume of isopropanol equal
to that of the aqueous phase. The DNA was pelleted by centrifugation at 15000xg for 10 min,
washed with 70% ethanol, dried under a vacuum using a SpeedVac (Thermo Corporation,
MA) and resuspended in Tris-chloride buffer. Losses in extraction of different samples were
kept constant by using constant volumes at all the steps.
Primer design and specificity testing. Primers sequences specific for the ASF
strains were obtained from a previous study (Sarma-Rupavtarm, Chapter 2). Primers for the
114
quantitative PCR (QPCR) of Citrobacter rodentium espB gene were modified from published
oligonucleotide sequences targeting the Citrobacter rodentium espB gene (McKeel, 2002) in
order to increase their dissociation temperature to a level optimal for QPCR (> 58*C), as
evaluated by using the PrimerExpress software (Applied Biosystems, CA). The specificity of
the primers was tested in silico by checking against Genbank by using the BLAST algorithm
and experimentally by amplifying DNA from C. rodentium in a background of fecal pellet
DNA from defined flora mice. The primers were also tested against E. coli and yielded no
amplicon. Primers espB-F and espB-R were synthesized and PAGE-purified by IDT DNA
Technologies (Coralville, IA). Amplifications were performed using the Platinum PCR kit
(Invitrogen, CA) on a Robocycler (Stratagene, CA) with the following conditions: 3 min at
94*C, 35 cycles of 1 min at 94'C, 1 min at 60'C, 2 min at 72*C. After PCR, the amplification
products were run on a 2% agarose gel (Invitrogen, CA) in Tris Borate EDTA buffer and
visualized on the EagleEye Gel documentation system (Stratagene, CA). Primers used in this
study are detailed in Table 1.
QPCR assay development Linearized plasmids containing the 16S rRNA gene of
each ASF strain were generated as specified in a previous study (Sarma-Rupavtarm, Chapter
2). For C. rodentium, the espB gene was amplified and cloned into a pCR2.1 plasmid vector
using the Topo-TA cloning kit (Invitrogen, CA). The plasmid was sequenced using the
BigDye terminator kit (Applied Biosystems, CA) to ensure that the primer regions were not
altered due to Taq polymerase error. Prior to use for generating standard curves, the plasmid
was linearized with the restriction enzyme BamHI (NEB, MA) that cuts the vector exactly
once outside the cloned espB gene. The concentrations of the linearized plasmid were
determined on a Synergy HT microplate fluorescence reader (Bio-Tek, VT) using the
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PicoGreen kit (Molecular Probes, OR) and dilutions of known concentrations of k DNA as
standards.
QPCR optimization. (i) MgC 2 optimization. MgCl2 concentrations as previously
optimized were used for QPCR of the ASF strains (Sarma-Rupavtarm, Chapter 2). C.
rodentium levels were quantified using Platinum® SYBR@ Green qPCR SuperMix-UDG kit
which contains a working concentration of 3 mM MgCl 2 . Hence, C. rodentium specific
primers were tested at this MgCl2 concentration in a background of DNA extracted from
fecal pellets from restricted flora mice, which harbor the ASF strains and a more complex
unknown flora, to ensure the absence of non-specific amplification. PCR conditions were the
same as those used for testing specificity. Amplification products were analyzed on a 2%
agarose gel (Invitrogen, CA) and visualized using the EagleEye gel documentation system
(Stratagene, CA).
(ii) Primer concentration. Primer concentrations, while increasing the efficiency of
QPCR reactions, can lead to primer dimer formation. Optimal primer concentrations for
QPCR of the ASF strains were obtained from Sarma-Rupavtarm (Chapter 2). For C.
rodentium QPCR, all combinations of 100 nM, 200 nM and 300 nM forward and reverse
primer concentrations were tested with approximately 106 copies of plasmid template bearing
the espB gene. QPCR reactions were performed in duplicate for each of the nine possible
primer concentration pairs, along with corresponding no-template controls, using the
Platinum@ SYBR® Green qPCR SuperMix-UDG kit (Invitrogen, CA) and the QPCR
conditions specified below. The primer concentrations yielding the lowest threshold cycle
value for the plasmid standard and highest threshold cycle value for the no-template control
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(300nM each of forward and reverse primer) were chosen as the optimal concentrations for
QPCR. None of the primers formed primer dimers at the optimal concentrations.
QPCR reaction conditions. All QPCR reactions were performed in triplicate on the
DNA Engine Opticon Continuous Fluorescence Detection System (MJ Research, MA).
Levels of ASF strains were quantified in a 25[d reaction volume using the SYBR Green core
reagents kit (Applied Biosystems, CA) and the following reaction conditions: 95'C 10 min,
40 cycles of: 95*C 30 sec, 60'C 45 sec, 72'C 75 sec. The MgCl2 concentration was kept
constant at 4.0 mM for all the reactions. QPCR reactions for C. rodentium were also
performed in triplicate on the Opticon System using the Invitrogen Platinum QPCR
Supermix (Invitrogen, CA), with a reaction volume of 25 d and the following reaction
conditions: 95'C 2 min, 40 cycles of: 95'C 30 sec, 60'C 45 sec, 72*C 75 sec. Melting curves
were generated post-QPCR to test for purity by identification of the characteristic melting
peak. This was done by measuring the fluorescence of the amplification product every 0.1 C
while increasing the temperature from 50'C to 95*C. Standard curves for individual ASF
strains and C. rodentium were generated using a ten-fold dilution series of the linearized
plasmid standard ranging from 1-10 copies. The fluorescence level for determining the
threshold cycle (CT) was set at 0.01 fluorescence units in all reactions. Some of the tissue
DNA samples had a very high background of eukaryotic DNA, which increased the
fluorescence background in the QPCR reactions. These samples were diluted ten-fold prior to
assay by QPCR.
Fluorescence in situ hybridization. i) Probes. Oligonucleotide probe sequences for
in situ hybridization of the ASF strains and C. rodentium were either designed in this study
or obtained from literature (Table 2). Probes for Mucispirillum schaedleri ASF457 and
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Clostridium sp. strain ASF356 were designed by identifying sequences unique to each strain
in a 16S rRNA secondary structure-based alignment of all eight ASF strains. Candidate
probes were selected based on published optimality criteria (Hugenholtz, 2001). Selected
candidate probe sequences were assessed for specificity by comparison against Genbank
using the BLAST algorithm and results indicating a perfect match only for the target
organism were chosen as FISH probes. Probes were ordered from ThermoElectron
Corporation GMBH (Bremen, Germany) and diluted in autoclaved milliQ water to a
concentration of 0.5 tg/ d. The universal eubacterial probe was labeled with Marina blue,
probes for the different ASF strains were labeled with Cy3 and the enterobacteriaceae probe
for C. rodentium was labeled with Oregon Green. The probes were used at 50 ng/[d working
concentration in the hybridization buffer.
ii) Sample preparation. Tissue samples embedded in OCT (Tissue-Tek) were cut on
a cryostat in 5 m thick sections onto Superfrost Plus Gold slides (Erie Scientific, NY).
Samples and slides were kept at -20'C or lower throughout the sectioning process, following
which they were stored at -80*C prior to hybridization.
iii) In situ hybridization. Whole cell hybridization protocols for fecal matter and
freshwater samples were modified for tissue (Barc, 2004, Hugenholtz, 2001). Briefly,
cryosectioned colonic samples were fixed for 3 h in 4% paraformaldehyde solution (Ph 7.2)
prepared in PBS (Hugenholtz, 2001). Following fixation, the slides were washed for 3 min in
PBS (pH 7.2) and 5 min in TE-HIS buffer (100mM Tris-Cl, 50mM EDTA). The sections
were treated for 10 min at room temperature in a 1mg/ml lysozyme (EM Sciences, NJ)
solution in TE-HIS buffer. Following this, the samples were dehydrated for 3 min each in
50%, 80% and 95% ethanol and air-dried. Hybriwell hybridization chambers (Molecular
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Probes/Invitrogen, CA) were affixed onto the samples to facilitate hybridization without
buffer evaporation. Hybridization buffer containing 102 mM NaCl, 20 mM Tris-HCl, 0.01%
SDS and 30% formamide used for all hybridizations, since this buffer composition has been
seen to work well when hybridizing with several probes with different dissociation
temperatures on a single section (Hugenholtz, 2001). For optimization of hybridization
conditions, two different sets of conditions (35*C hybridization/ 37*C wash (Barc, 2004) and
46*C hybridization/48*C wash (Hugenholtz, 2001)) were assessed on an artificial mixture of
Lactobacillus murinus ASF361 (Gram positive) and Citrobacter rodentium (Gram negative).
The two strains were grown overnight in MRS broth (Difco, MI) and LB broth (Difco, MI)
respectively, and harvested by centrifugation at 8000xg for 5 min. The cell pellets were
resuspended in sterile water, pooled and spotted onto SuperFrost Plus slides (Erie Scientific,
NY). The cells were hybridized with the universal EUB338, lactobacilli-specific LAB 158
and enterobacteriaceae-specific ENTER1532 probes using the above protocol for 2 h. The
35*C hybridization was washed for 15 min at 37'C with Wash Buffer I containing 65 mM
NaCl, 5 mM Tris-HCl, 5 mM EDTA and 0.01% SDS (Barc, 2004), while the 46*C
hybridization was washed for 15 min at 48'C in Wash Buffer II containing 102 mM NaCl, 20
mM Tris-HCI and 0.01% SDS (Hugenholtz, 2001). Following washing, the samples were
rinsed in ice cold water and air-dried. The samples were cover-slipped after the addition of
Vectashield Hardset medium with DAPI (Vector Labs, CA). The higher hybridization/wash
temperature conditions yielded a strong specific signal while nonspecific hybridization was
seen with the lower temperature set. Thus, all hybridizations were performed for 2 h at 46*C,
followed by a 15 min wash in Buffer II.
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iv) Immunofluorescence for C. rodentium. Briefly, tissue sections were subjected to
heat-induced epitope retrieval in sodium citrate buffer at pH 6.0, followed by incubation with
the primary antibody at 1:1500 dilution for 1 hour. Sections were subsequently washed with
PBS and incubated with goat anti-rabbit secondary antibody conjugated to Alexa Fluor 488
dye (Molecular probes) at 1:100 dilution for 30 minutes. DAPI was used as a counter stain.
v) Fluorescence microscopy and image analysis. Hybridized samples were viewed
on a Zeiss Axioskop epifluorescence microscope (Carl Zeiss, NY) with filters with the
following excitation emission characteristics: 360 nm/460 nm (DAPI, Marina Blue), 470
nm/535 nm (Oregon Green) and 546 nm/580 nm (Cy3). Images were captured with a Nikon
D70 digital camera (Nikon, NY) in 8-bit TIFF format. Image analysis was performed using
Photoshop 7.0 (Adobe, CA). All images are shown in false color here.
Statistical analysis. Cell numbers from infected and control groups were analyzed
using Microsoft Excel for statistically significant differences using Analysis of Variance
(ANOVA). Statistical significance was set at P < 0.05.
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RESULTS
C. rodentium infection in Defined Flora C.B-17 SCID mice. Citrobacter rodentium
levels assessed by QPCR over the course of the study in three regions of the large intestine,
viz. ileocecal valve, proximal colon and distal colon, showed differences depending on the
day of sampling and the region sampled. C. rodentium reached levels of greater than 105
cells/g tissue by the first post-infection (PI) sampling time point at Day 3 in all three regions,
but only reached a peak level of 107-8 cells/g tissue in all three regions of the large intestine
(Figure IA, B & C). C. rodentium was present at a level of over 107 cells/g tissue by Day 3
PI in the ileocecal valve and stayed at this level over the course of the infection study
(Figure 1A). In the proximal colon, C. rodentium levels increased by an order of magnitude
over the course of the infection, from about 106 cells/g tissue at Day 3 to about 107 cells/g by
Day 6 and were stable at this level (Figure 1B). Average C. rodentium levels were at 106 to
107 cells/g tissue in the distal colon over the course of the infection. However, while the
numbers did not vary much between different infected mice at Day 3 and Day 6 PI, there was
over 2 orders of magnitude difference (106 to 108) between different mice at both Day 14 and
Day 21 (Figure 1C). Surprisingly, the number of cells of the pathogen per gram of tissue
were highest upstream of the distal colon in the ileocecal valve and proximal colon
throughout the course of the infection, although the distal colon has been seen to be the site
of pathology due to C. rodentium-induced colitis.
Despite the substantial levels of C. rodentium, infection in the C.B-17 SCID mice led
only to low levels of disease in the mice, as observed on Day 14 P1. Examination of
hematoxylin and eosin stained colonic tissue showed a low level of colonic hyperplasia in the
infected mice as compared to the control mice (Figure 2). The formed fecal pellets in the
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mice euthanized on Day 14 PI were soft, but the mice showed no obvious behavioral signs of
disease.
Bulk population effects of C. rodentium infection on altered Schaedler flora. Bulk
levels of all the ASF strains were enumerated in the ileocecal valve, proximal colon and
distal colon for all four temporal data points. Infection by C. rodentium was associated with
subtle changes in the bulk population levels of specific ASF strains that varied both over the
time course of the infection and in the different regions of the GI tract assayed. Surprisingly,
all changes involved an increase in the level of the ASF strain in infected mice as compared
to control mice. Total bacterial levels were higher in infected mice than in control mice in all
three colonic regions at Day 3 PI, and in the proximal and distal colon on Day 6 PI. Levels of
total bacteria were similar in both groups after Day 6 PI.
The most significant differences in abundance were seen in the ileocecal valve at Day
3 PI. Levels of Clostridium sp. strains ASF356 (109-10 cells/g vs. 108 cells/g) and ASF500
(108 cells/g vs. 107 cells/g), Lactobacillus murinus ASF361 (107 cells/g vs. 106 cells/g),
Mucispirillum schaedleri ASF457 (1010 cells/g vs. 109 cells/g) and Bacteroides sp. strain
ASF519 (1010 cells/g vs. 109 cells/g) were all seen to be significantly higher (P<0.05) in
infected mice than in control mice (Figure 3). No significant differences were seen in the
ileocecal valve at Day 3 PI for Eubacterium plexicaudatum ASF492 and Clostridium sp.
strain ASF502. Lactobacillus sp. strain ASF360 was not detected in any of the mice,
consistent with previous observations (Sarma-Rupavtarm, Chapter 2).
There were no significant differences in bacterial levels at Day 6, Day 14 and Day 21
PI (Supplementary figures, S1-4) with the exception of low levels of Eubacterium
plexicaudatum ASF492 and Clostridium sp. strain ASF500 in control mice on Day 6 PI,
122
which were probably abnormal and due to animal to animal variation. No contaminants were
detected in feces from the mice by culture tests. However, the numbers were at previously
observed levels in the control mice on day 14 PI and beyond. Other than these changes, no
significant differences were observed between infected and control mice for any of the ASF
strains, and the levels of the ASF strains in the two groups were statistically indistinguishable
in the regions studied on the different sampling time points.
Microscale effects on altered Schaedler flora. Infection with C. rodentium did not
cause any changes in the localization of the ASF strains that could be observed by comparing
the infected and control mice. The intestinal cross-section could be divided into three regions
where bacteria appeared to be localized, in the lumen, at the lumen-mucus interface or inside
the mucus. Different ASF strains showed distinct spatial localization across the mucosal-
luminal cross-section that was consistent over time, and between the infected and control
groups. Interestingly, bacterial colonization was patchy and some regions of the mucus or the
lumen appeared not to be colonized by any bacteria.
Specific ASF strains were located consistently in one or more of the three regions.
However, no differences were seen between infected and control mouse sections in the
location of the ASF strains assayed for by FISH. The two most abundant ASF strains appear
to have different spatial niches. Mucispirillum schaedleri ASF457, whose bulk levels as
assessed by QPCR assays were an order of magnitude higher than most of the other ASF
strains in different sections of the large intestine, was the only ASF strain localized within the
mucus layer (Figure 4A&B). M. schaedleri ASF457 was also the only bacterium identified
close to the base of the crypts, embedded deeply in the mucus layer. The other abundant ASF
strain, Bacteroides sp. strain ASF519, was primarily localized in the lumen, unattached to the
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mucus layer (Figure 4C&D). Other ASF strains assayed for were also present at specific
locations across the mucosal-luminal continuum. Clostridium sp. strain ASF356 was seen in
the lumen or attached to the mucus or, but never in the mucus layer (Figure 4E). Clostridium
sp. strain ASF500 was present attached to or near the mucus layer (Figure 4F).
Surprisingly, C. rodentium was not conclusively detected in sections from infected
mice either by FISH with the Enterobacteriaceae probe or immunofluorescence with anti-
Citrobacter rodentium antibodies. Bulk C. rodentium levels as measured by QPCR assays
would indicate greater than 10 cells per field even in the ileocecal valve sections where C.
rodentium makes up less than 0.1% of the total population.
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DISCUSSION
Studies on the interaction of the GI microbiota with exogenous pathogens have
primarily focused on the disease-ameliorating role of the bacteria. There is an abundance of
evidence in literature suggesting a role for the GI microbiota in reducing the severity of
disease caused and increasing the needed infectious dose of the pathogen (Wells, 1982,
Kennedy, 1986, Hudault, 2001, Hopkins, 2003, Vollaard, 1994). The mechanisms behind the
role of the microbiota are not well understood and one proposed hypothesis invokes
competition for adherence sites between the exogenous pathogen and the intestinal
microbiota (Kennedy, 1987). However, studying the microecology of infection in depth in an
ecosystem of hundreds of species of bacteria is an intractable problem. Experimental setups
to study GI microbiota-pathogen interactions have involved either simplification of the
microbiota by antibiotic treatment or simple defined flora models such as mono-associated
germfree mice. While both approaches provide insight into the role of the complex flora as a
whole or of two-species interactions, the former cannot resolve fine-scale interactions
whereas the latter are difficult to generalize, as one species is not representative of the
diversity of the complex flora. To complement these two approaches, our study used
gnotobiotic mice with a more complex defined flora that is representative of the abundant
intestinal bacterial species. The mouse pathogen, Citrobacter rodentium, was chosen since it
causes a mild self-limiting disease and prior studies have indicated that the infection reaches
a peak by day 14 post-infection. A short time line of infection is critical to defined flora
experiments in order to minimize the potential for contamination from cage changes and
other husbandry requirements. The aim of this study was to examine the ecology of infection
by a pathogen in the GI tract in a defined flora mouse model which, while sacrificing some
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level of complexity, allows for analysis of both bulk population dynamics as well as
microscale spatial effects of infection.
The dynamics of C. rodentium infection in the C.B-17 defined flora model were
different from previously observed results in other mouse models. Surprisingly, the levels of
C. rodentium in defined flora mice in this study reached a high level of 10 6-7cells/g tissue by
Day 3 PI and increased only by an order of magnitude by Day 6 PI. The variation over the
course of the experiment was within one order of magnitude in the ileocecal valve and
proximal colon, while there was higher variability in the distal colon on the later sampling
dates. In addition, C. rodentium levels were consistently observed to be higher upstream of
the distal colon, which is seen to be the site of pathology. While no studies have assessed the
colonization dynamics of C. rodentium in defined flora immunodeficient mice, studies
conducted in immunodeficient RAG k/o mice harboring a flora of unknown complexity have
indicated an increase in C. rodentium levels from about 10( CFU/colon (colon weight is
approximately 0.1 grams) at Day 4 PI to about 108 CFU/colon (Vallance, 2002). In studies of
immunocompetent mice harboring a flora of unknown complexity, C. rodentium levels
increased from less than 104 CFU/colon at Day 4 PI to about 108 CFU/colon at Day 6 PI
(Vallance, 2003). Thus, C. rodentium reaches a high level of colonization in defined flora
immunodeficient mice at an earlier time point post infection than immunodeficient or
immunocompetent mice with a flora of unknown complexity.
One possible explanation for the observed dynamics in our experiment is the difference
in complexity between the intestinal flora in mice in previous studies and the defined flora
mice used in our study. The vendor used in our study, Taconic, is the only one that maintains
production stock immunodeficient SCID mice in strict defined flora conditions (Sarma-
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Rupavtarm, Chapter 3). It is highly likely that the mice in other studies, from vendors other
than Taconic, harbored a more complex flora than the eight ASF strains. In particular,
facultatively anaerobic organisms such as E. coli are known to colonize the GI tract of
animals, although only as a small proportion of the colonic flora. While the altered Schaedler
flora is representative of the obligate anaerobic and aerotolerant components of the complex
microbiota, it does not include a facultatively anaerobic strain. From a competition
standpoint, it is possible that the facultatively anaerobic C. rodentium faces the biggest
challenge from a facultative member of the complex microbiota. Potentially, resistance to
colonization of a pathogen mediated by the intestinal flora could be effected by competition,
possibly for a spatial niche, between the pathogen and components of the microbiota
physiologically most similar to the pathogen. Colonizing defined flora mice with E. coli prior
to Citrobacter rodentium infection would provide more information on the validity of this
hypothesis. Alternately, the defined flora mice could be infected with an anaerobic pathogen
and assessed for competition between the pathogen and the obligate anaerobes among the
ASF strains.
Another interesting observation from our results is that the ileocecal valve is a primary
site of colonization of C. rodentium, with high levels of the pathogen being seen by Day 3 PI.
This corroborates the results of a recent study in specific pathogen free C57/BL6 mice, where
the infection dynamics were studied with a genetically engineered C. rodentium strain that
expressed a bioluminescent pathway (Wiles, 2004). Since the distal colon is a site where
pathology due to C. rodentium infection is commonly seen (Luperchio, 2001), it is interesting
to observe that C. rodentium levels are consistently higher in the ileocecal valve and
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proximal colon, potentially indicating that tissue/organ specificity of C. rodentium is not
necessarily correlated with pathogenesis.
The effect of C. rodentium infection on bulk levels of ASF strains is nuanced and
unexpected. Our study indicates that infection by C. rodentium leads to statistically
significant increases (P< 0.05) in the levels of specific ASF strains in infected mice as
compared to control mice at Day 3 PI. Further, the total number of bacteria/g of tissue was
higher in infected mice than in control mice at Day 3 PI. The contribution of C. rodentium
levels to this increase was minimal, with the pathogen representing less than a few percent of
the total cells. A statistically significant difference in levels was also seen in feces from
infected and control mice at Day 3 PI (data not shown). This dynamic changed over the
course of the infection, with the total numbers of cells/g tissue similar after Day 6 PI in both
infected and control mice.
A potential reason for the increase in the overall bacterial numbers could be the presence
of additional nutrients from an increased sloughing of epithelial cells in response to infection.
The GI tract ecosystem has been called a precarious alliance between the host immune
system and the intestinal microbiota, wherein a tolerance is developed for the intestinal
bacteria (McCracken, 2002). In this context, the increase in resident bacterial populations
may be one of the factors that could potentially cause a breakdown in the equilibrium
between the host and the microflora in susceptible individuals. This may have implications in
diseases of immune system dysregulation, such as inflammatory bowel disease, where, for
reasons not understood, the body mounts an uncontrolled inflammatory response to the
intestinal microbiota antigens.
12R
The microscale spatial architecture data from FISH indicates that the ASF bacteria have
specific niches in both infected and control mice. While this could indicate that infection
with C. rodentium does not detectably alter the spatial architecture of the ASF strains across
the GI cross-section, it is difficult to make this assertion, given the lack of strong results
correlating the spatial colocalization of C. rodentium with ASF strains. A prior study that
examined the microscale interactions between an E. coli strain (exogenous) and B. vulgatus
(monoassociated with mice) observed that the exogenous strains did not overlap with or
displace the resident bacterial species (Waidmann, 2003).
While immunofluorescence data indicated a few stained cells at the lumen-mucus
interface, the high background and low number of cells that stained made definitive
identification of the cells as C. rodentium difficult. Similar results were observed with FISH,
where a signal was visible in a few sections, but in a high background, precluding definitive
identification. The immunofluorescence results could potentially be due to the usage of
frozen sections, on which the protocol has not been optimized. In future experiments, C.
rodentium cells will be immobilized in OCT, flash frozen and sectioned similar to tissue, and
the immunofluorescence protocol will be optimized on these sections prior to use on
sectioned tissue. The FISH results for C. rodentium could potentially be due to the relative
short length of the probe, which was 15 nucleotides long., which could also potentially
explain the high background seen. The probe will be lengthened prior to use in future
experiments in order to increase specificity.
The spatial localization of the ASF strains indicated that strains were likely to be present
at one or more of three regions: the lumen, the lumen-mucus interface or inside the mucus
layer. Two of the most abundant ASF strains as measured by QPCR, Bacteroides sp. strain
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ASF519 and Mucispirillum schaedleri ASF457, appear to have different niches wherein M.
schaedlerii ASF457 is primarily located in or at the mucus layer and Bacteroides sp. strain
ASF519 is primarily free-living in the lumen.
The role of the microbiota in colonization resistance is hard to assess due to the
complexity of the bacterial species. This study indicates that infection may initially be
associated with an increase in total bacterial numbers, and the relative stability of the
microbiota in response to infection, combined with the accelerated dynamics of infection, in
the ASF mouse model suggests that colonization resistance effects may potentially be
dependent on bacteria similar in physiology to the pathogen. Studies with anaerobic
pathogens in the ASF model will provide more insight into the potential relationship
physiological similarities and colonization resistance. Further, the understanding derived on
the spatial distribution of some of the ASF strains will help in the development of testable
microecological hypotheses on the role of mucosal vs. luminal bacteria. Thus, future
experiments in the defined flora mouse models on pathogen-microflora-host interactions hold
the potential to yield insight into the role of our microbial cohabitants in preventing disease.
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FIGURE LEGENDS
Figure 1. The levels of C. rodentium (cells/g tissue) over the four sampling days post-
infection as measured by QPCR in a) ileocecal valve, b) proximal colon and c) distal colon,
are shown here. The three different infected mice from which the samples were collected
after euthanizing them are represented by a filled circle (0), filled square (M) and filled
diamond (*).
Figure 2. Defined flora C.B-17 SCID mice infected with C. rodentium exhibit a low level of
hyperplasia, as seen in hematoxylin & eosin-stained colonic sections from mice euthanized
on Day 14 post-infection. The two leftmost panels are from control mice, while the middle
and rightmost panels are from infected mice.
Figure 3. The levels of C. rodentium and the seven ASF strains (cells/g tissue) measured in
the ileocecal valve of infected and control mice by QPCR on Day 3 PI are shown. C. rod: C.
rodentium, 356: Clostridium sp. ASF356, 361: Lactobacillus murinus ASF361, 457:
Mucispirillum schaedleri ASF457, 492: Eubacterium plexicaudatum ASF492, 500:
Clostridium sp. ASF500, 502: Clostridium sp. ASF502 and 519: Bacteroides sp. ASF519.
Infected mice are represented by a filled circle (0), filled square (0) and filled diamond (*)
while control mice are represented by a light-colored upward triangle (A) and downward
triangle (V).
Figure 4. Representative images from intestinal sections hybridized with labeled probes
specific for a) & b) Mucispirillum schaedleri ASF457 (40X and lOOX magnification), c) &
d) Bacteroides sp. strain ASF519 (40X and lOOX magnification), e) Clostridium sp. strain
ASF356 (lOOX magnification) and f) Clostridium sp. strain ASF500 (lOOX magnification)
are shown here. M. schaedleri ASF457 is seen localized in the mucus layer deeply embedded
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in the crypt at lOOX magnification. All images are in false color, with blue representing
EUB338 and DAPI fluorescence, and red representing an ASF strain-specific probe
fluorescence.
Supplemental figure 1. The levels of C. rodentium and the seven ASF strains (cells/g tissue)
measured by QPCR in a) proximal colon and b) distal colon of infected and control mice on
Day 3 PI are shown. C. rod: C. rodentium, 356: Clostridium sp. ASF356, 361: Lactobacillus
murinus ASF361, 457: Mucispirillum schaedleri ASF457, 492: Eubacterium plexicaudatum
ASF492, 500: Clostridium sp. ASF500, 502: Clostridium sp. ASF502 and 519: Bacteroides
sp. ASF519. Infected mice are represented by a filled circle (0), filled square (U) and filled
diamond (*) while control mice are represented by a light-colored upward triangle (A) and
downward triangle (V).
Supplemental figures 2-4 The levels of C. rodentium and the seven ASF strains (cells/g
tissue) measured by QPCR at Day 6 PI (Figure S2), Day 14 PI (Figure S3) and Day 21 PI
(Figure S4) in a) proximal colon and b) distal colon, and c) ileocecal valve of infected and
control mice are shown. C. rod: C. rodentium, 356: Clostridium sp. ASF356, 361:
Lactobacillus murinus ASF361, 457: Mucispirillum schaedleri ASF457, 492: Eubacterium
plexicaudatum ASF492, 500: Clostridium sp. ASF500, 502: Clostridium sp. ASF502 and
519: Bacteroides sp. ASF519. Infected mice are represented by a filled circle (0), filled
square (0) and filled diamond (*) while control mice are represented by a light-colored
upward triangle (A) and downward triangle (V).
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TABLE 1. Primer sequences and QPCR parametersa used in the study.
Strain name
Species/group
Clostridium sp. ASF356
Lactobacillus sp. ASF360
Lactobacillus murinus ASF361
Flexistipes gp. ASF457
Eubacterium plexicaudatum
ASF492
Low-G+C-content gram positive
gp. ASF500
Clostridium sp. ASF502
Bacteroides sp. ASF519
Citrobacter rodentium
espB-648R CAGCAGTAAAGCGACTTAACAGATT (300)
a MgClconcentration for ASF QPCR was 4 mM, as optimized in Sarma-Rupavtarm, Chapter 2. MgCl,
concentration in C. rodentium QPCR mastermix was 3 mM.
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Forward and reverse primers (concentration used in QPCR
reaction, nM)
356-144F CGGTGACTAATACCGCATACGG (100)
356-538R CCTTGCCGCCTACTCTCCC (100)
360-8 IF CTTCGGTGATGACGCTGG (300)
360-189R GCAATAGCCATGCAGCTATTGTTG (200)
361-278F GCAATGATGCGTAGCCGAAC (200)
361-435R GCACTTTCTTCTCTAACAACAGGG (300)
457-130F CCGAAAGGTGAGCTAATGCCGG (100)
457-219R GGGACGCGAGTCCATCTTTC (100)
492-57F CTGCGGAATTCCTTCGGGG (100)
492-204R CCCATACCACCGGAGTTTTC (100)
500-183F GTCGCATGGCACTGGACATC (200)
500-445R CCTCAGGTACCGTCACTTGCTTC (200)
502-195F CGGTACCGCATGGTACAGAGG (200)
502-600R CAATGCAATTCCGGGGTTGG (300)
519-834F CACAGTAAGCGGCACAGCG (200)
519-1243R CCGCTCACACGGTAGCTG (200)
espB-403F CTGCTTCTGCGAAGTCTGTCAA (300)
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Table 2. Probes used in the study
Name Target Sequence (5'-3') Reference
EUB338 Eubacteria GCTGCCTCCCGTAGGAGT Amann, 1990
Bact 1080 Bacteroides GCACTTAAGCCGACACCT Dore, 1998
Lab 158 Lactobacillus-Enterocc GGTATTAGCACCTGTTTCCA Harmsen, 1999
Enter1432 Enterobacteriaceae CTTTTGCAACCCACT Sghir, 2000
ASF500 ASF500 CAATGTGGCCGGCCAACC Schuppler, 2004
ASF356 ASF356 TCCACAGTAAAAGGCAGGTTGCC This study
ASF457 ASF457 GGGACGCGAGTCCATCTTTC This study
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SUMMARY
This aim of this thesis is to understand aspects of the microbial ecology of the
mammalian GI tract through a multi-species functional defined flora mouse model, the
altered Schaedler flora (ASF). The overall goals of the thesis were to
A) establish a set of molecular biological tools targeting the ASF strains with which
complex interactions in the GI tract could potentially be studied,
B) demonstrate the viability of the model by assessing the presence of the ASF strains in
mice from commonly used vendors that have potentially acquired a flora of higher
complexity and,
C) conduct the first in-depth study of the interactions between a functional multi-species
GI microflora and a pathogen, at both a bulk population level and at a microscale
spatial level.
The result of the first part of the thesis demonstrate that the ASF strains are present at
high levels in the GI tract of mice, following a pattern of strain abundance that mirrors the
oxygen tolerance of the strain and oxygen levels in the different regions of the GI tract. It
was also shown that the fecal levels of ASF strains do not correlate well with the colonic
levels, thus indicating that studies inferring colonic levels or relative abundance of bacteria
from fecal abundances have to be interpreted cautiously. Results from the second part of
thesis indicate that a majority of the ASF strains are indeed a stable part of the mouse GI
ecosystem, even in the face of competition, and their presence and abundance further
validates the use of the ASF mouse model to study aspects of gastrointestinal microbial
ecology.
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The third part of the thesis yielded several surprising results. Firstly, it was seen that
infection by a colonic pathogen leads to an initial increase in the total levels of the ASF
strains. Secondly, it was seen that the perturbation from an exogenous pathogen is minimal,
and the ASF strain levels remain fairly stable through the course of an infection. While it was
not possible to conclusively establish colocalization of the pathogen with the ASF strains, the
spatial localization of the ASF strains did not change between across the luminal-mucosal
cross-section. These results could indicate that interactions between a pathogen and the GI
microflora may be a complex process, involving more than solely a competition for adhesion
to the gut wall. The tools developed in this thesis and the results of the pathogen-microflora
interaction study provide a basis for designing further studies to understand several aspects of
GI microbial ecology.
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